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ABSTRACT OF DISSERTATION

MECHANISTIC INVESTIGATIONS OF THE TRANS EXCISION-SPLICING AND
TRANS INSERTION-SPLICING REACTION
Group I intron-derived ribozymes are catalytic RNAs that have been engineered
to catalyze a variety of different reactions, in addition to the native self-splicing reaction.
One such ribozyme, derived from a group I intron of Pneumocystis carinii, can modify
RNA transcripts through either the excision or insertion of RNA sequences. These
reactions are mediated through the trans excision-splicing (TES) or trans insertionsplicing (TIS) reaction pathways. To increase our current understanding of these
reactions, as well as their general applicability, a mechanistic and kinetic framework for
the TES reaction was established. Furthermore, additional ribozymes were investigated
for their ability to catalyze the TES reaction. Lastly, the development of the TIS reaction
into a viable strategy for the manipulation of RNA transcripts was investigated.
The TES reaction proceeds through two reaction steps: substrate cleavage
followed by exon ligation. Mechanistic studies revealed that substrate cleavage is
catalyzed by the 3’ terminal guanosine of the Pneumocystis ribozyme. Moreover, kinetic
studies suggest that a conformational change exists between the individual reaction steps.
Intron-derived ribozymes from Tetrahymena thermophila and Candida albicans were
also investigated for their propensity to catalyze the TES reaction. The results showed
that each ribozyme could catalyze the TES reaction; however, Pneumocystis carinii is the
most effective using the model constructs.
Investigations of the TIS reaction focused on developing a new strategy for the
insertion of modified oligonucleotides into an RNA substrate. These studies used
oligonucleotides with modifications to the sugar, base, and backbone positions. Each of
the modified oligonucleotides was shown to be an effective TIS substrate. These results
demonstrate that TIS is a viable strategy for the incorporation of modified
oligonucleotides, of varying composition, into an intended RNA target.
The results from these studies show that group I introns are highly adaptable for
catalyzing non-native reactions, including the TES and TIS reactions. Furthermore, group
I introns are capable of catalyzing these unique reactions through distinct reaction
pathways. Overall, these results demonstrate that group I introns are multi-faceted
catalysts.
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CHAPTER ONE-SUMMARY
Ribonucleic acids, or RNA, are vital biomolecules in that they play a pivotal role
in the pathway by which the genetic information stored within a cell is expressed. Prior to
the 1980’s, the role of RNA was thought to be an intermediate in the pathway of
expression of proteins from deoxyribonucleic acids (DNA). The discovery of catalytic
RNA resulted in the reclassification of RNA (1, 2). These discoveries ultimately led to
the identification of many catalytic RNAs which are found in a variety of differing
organisms. These include plants, bacteria, viruses, lower eukaryotes, and a few mammals
(3-7). In the last twenty-five years, the manipulation of these catalytic RNAs, termed
ribozymes, has shown that they can perform a variety of enzymatic reactions previously
thought to be catalyzed only by protein enzymes (3, 6).
One previously characterized ribozyme-mediated reaction, catalyzed by a group I
intron-derived ribozyme from the fungal pathogen Pneumocystis carinii, results in the
site-specific excision of predefined regions from within RNA transcripts (8). The
reaction, termed trans excision-splicing (TES), has previously been shown to be a viable
strategy for the manipulation of RNA sequences in vitro, as well as in vivo (8, 9). The
manipulation of RNA sequences, particularly in vivo, could potentially lead to the
development of TES into a therapeutic strategy for the correction of mutated RNA
transcripts (9). The TES reaction also provides a unique model system for the study of
RNA catalysis.
Another recently characterized ribozyme-mediated reaction, termed trans
insertion-splicing (TIS), has been developed for the site-specific insertion of
oligonucleotides into RNA transcripts (10). Similar to the TES reaction, the TIS reaction
is catalyzed by a group I intron-derived ribozyme from Pneumocystis carinii (10). The
TIS reaction has potential as a strategy for the manipulation of RNA sequences,
specifically the insertion of modified oligonucleotides into RNA transcripts.
Previous investigations of the TES reaction have led to questions relating to the
overall reaction mechanism, specifically regarding the first reaction step. The research
presented herein investigates the fine details of the TES reaction through mechanistic as
well as kinetic characterization of the first reaction step of TES. Furthermore, ribozymes
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other than that from Pneumocystis carinii were investigated for their ability to catalyze
the TES reaction. With respect to the TIS reaction, the potential of TIS being developed
into a viable strategy for the insertion of modified oligonucleotides was investigated to
ascertain its feasibility.
Investigation of the Reaction Mechanism for the Trans Excision-Splicing Reaction
Previous investigations of the TES reaction suggest the first reaction step
(substrate cleavage) was catalyzed through ribozyme-mediated 5’ hydrolysis (8). An
alternative explanation is that an endogenous nucleotide, specifically one at the 3’
terminal position of the ribozyme, acts as an intramolecular nucleophile. In this case,
substrate

cleavage

is

catalyzed

through

ribozyme-mediated

intramolecular

transesterification. To distinguish between the two possible reaction mechanisms, the
unique reaction intermediates that would be produced in each mechanism were analyzed.
The results demonstrate that the substrate cleavage reaction of TES is catalyzed
through ribozyme-mediated intramolecular transesterification. Specifically, the 3’
terminal guanosine of the ribozyme acts as an intramolecular nucleophile. This
conclusion is based on several lines of evidence, including the isolation of TES ribozyme
intermediates from previously characterized in vitro and in vivo model systems.
Sequencing of TES ribozyme intermediates demonstrate a portion of the RNA substrate
becomes covalently attached to the 3’-end of the ribozyme. Surprisingly, TES ribozyme
intermediates isolated in vivo demonstrate that the ribozyme undergoes a self-truncation
process, thereby acquiring a reactive 3’ terminal guanosine. These results have greatly
enhanced our current understanding of the overall mechanism for the TES reaction. For
future TES studies, the mechanistic insights gained will potentially lead to an increase in
the likelihood of successful TES reactions conducted in vitro and in vivo.

Kinetic Characterization of the First Step of the TES Reaction
Previous investigations of ribozyme-mediated reactions have established kinetic
frameworks for gaining insight into the fundamental aspects of RNA catalysis. These
previous studies have been informative with regard to the chemical and mechanistic
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aspects of ribozyme-mediated reactions. Previously, a possible mechanistic pathway for
the first and second reaction steps of the TES reaction has been proposed based on our
current understanding of other ribozyme-mediated reactions (8, 11-17). Prior TES
reports, however, have not focused on the individual reaction steps in detail, and rate
constants for individual steps have not been determined. Thus, a minimal kinetic scheme,
in conjunction with another member of the Testa lab (Joy Sinha), was established for the
first step of the TES reaction. These studies were undertaken to increase our fundamental
understanding of the mechanism for TES, as well as for RNA catalysis in general.
The results obtained from the kinetic scheme for the first reaction step (substrate
cleavage) showed that the rate constants for both substrate cleavage and substrate
dissociation are comparable and that the true rate for the chemical step is being masked
by a conformational change. Additionally, the relatively slow rate of product dissociation
suggests that it is rate-limiting with respect to the possibility of multiple-turnover
reactions. The insights obtained have greatly enhanced our current understanding of the
fine details with respect to the first step of the TES reaction.
The Trans Excision-Splicing Reaction Can be Catalyzed by Group I Intron-Derived
Ribozymes from Tetrahymena thermophila and Candida albicans
Previous investigations of the TES reaction have focused on the group I intronderived ribozyme from Pneumocystis carinii (8, 9, 18, 19). Structurally, previously
characterized intron-derived ribozymes are similar to Pneumocystis carinii in that all the
fundamental structural elements required to perform the TES reaction are present. This
suggests that other group I intron-derived ribozymes could potentially catalyze the TES
reaction. If true, it would be informative to know the relative effectiveness of these
ribozymes. To address this possibility, the group I intron-derived ribozymes from
Tetrahymena thermophila and Candida albicans were modified to investigate their ability
to catalyze the TES reaction.
The results demonstrate that the intron-derived ribozymes from Tetrahymena
thermophila and Candida albicans can catalyze the excision of a single nucleotide from
within respective RNA substrates. In addition, both ribozyme constructs catalyze the
substrate cleavage reaction through ribozyme-mediated intramolecular transesterification.
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Both ribozyme constructs, however, show decreased efficiencies for catalyzing the
individual steps of the TES reaction compared to the Pneumocystis carinii ribozyme.
This was determined to be due to the individual ribozyme’s ability to effectively utilize
their 3’ terminal guanosine as an intramolecular nucleophile. Nevertheless, our results
show that the TES reaction can be catalyzed by at least three different group I intronderived ribozymes. Apparently, being able to catalyze the TES reaction is a common
property of group I intron-derived ribozymes.
Insertion of Modified Oligonucleotides using the Trans Insertion-Splicing Reaction
The site-specific modification of RNA transcripts has lead to more in-depth
studies of the structural and functional aspects of RNA. Current methods for synthesizing
full-length modified RNA transcripts, however, have been problematic, in some cases
suffering from a lack of product specificity and low product yields. The TIS reaction was
recently developed to site-specifically insert oligonucleotides into a RNA substrate (10).
The next step is to determine whether the TIS reaction could be developed into a new
methodology for the insertion of modified oligonucleotides into RNA transcripts. To test
the feasibility of this strategy, a test system was developed that uses modified
oligonucleotides as TIS substrates, including substrates with single and double
modifications. For this proof-of-principle study, five modifications were used, including
those to the ribose sugar (deoxy or methoxy substitution), base (2-aminopurine or 4thiouridine), or phosphodiester backbone (thiol substitution).
The results demonstrate that the TIS reaction is a viable strategy for the insertion
of modified oligonucleotides into RNA targets. For the five modified oligonucleotides
tested, each was inserted sequence-specifically into their intended RNA targets, and
yields ranged from 60-70%. Furthermore, the TIS strategy was shown to be effective at
inserting oligonucleotides with double modifications. These results are encouraging in
that the TIS strategy is potentially a new method for the synthesis of full-length modified
RNA transcripts.
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CHAPTER TWO-BACKGROUND
The Central Dogma of Molecular Biology.
In 1958 (20), Francis Crick proposed ‘the central dogma of molecular biology’ to
describe the flow of genetic information within a cell (Figure 2.1). In all known cell
types, the genetic information is found in the form of deoxyribonucleic acids, or DNA.
For the information contained within cellular DNA to be converted into something
useful, the DNA is first used as a template for the production of ribonucleic acids, or
RNA. This process, known as transcription, results in a RNA transcript that is identical to
the sequence of the DNA except for the substitution of thymine for uracil (see following
sections). The resulting RNA transcript is further modified post-transcriptionally to yield
the mature RNA species.
In the case of messenger RNA, the resulting RNA transcript is subsequently used
as a template for the production of a protein product through the process of translation.
Messenger RNA transcripts are divided into groups of three consecutive RNA residues,
termed codons, that code for the twenty naturally occurring amino acids. During
translation, each amino acid is subsequently added to the elongating polypeptide chain,
through the formation of peptide bonds. The resulting protein product is further modified
post-translationally, in some instances, to yield the final protein product. In later studies,
RNA was also found to be used as a template for the synthesis of a complementary DNA
molecule. These later discoveries, including reverse transcription, resulted in the
modification of the overall scheme of the central dogma (21).
Nucleic Acids
Nucleic acids are naturally occurring biopolymers consisting of the monomeric
subunits termed nucleotides. The two classes of nucleic acids, deoxyribonucleic and
ribonucleic acids differ structurally, which contribute to their unique chemical and
functional properties.
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Deoxyribonucleic Acid
Deoxyribonucleic acid, or DNA, consists of a 2’-deoxyribose sugar with three
distinct components attached (Figure 2.2A). These include a 3’ hydroxyl group, a
heterocyclic nucleobase, and a 5’ phosphate group (22). DNA can be further
differentiated into four distinct nucleotides by the identity of the heterocyclic nucleobase.
Purines, which include adenine (A) and guanine (G), and pyrimidines, which include
thymine (T) and cytosine (C) (Figure 2.3). Note that purines are monocyclic compounds
while pyrimidines are bicyclic compounds.
Individual nucleotides are attached through phosphodiester bond linkages. This
occurs through the covalent attachment of a phosphate group between the 5’ hydroxyl of
one nucleotide to the 3’ hydroxyl of an adjacent nucleotide. Note, the resulting
phosphodiester backbone of DNA has directionality in the 5’ to 3’ direction (Figure 2.4).
Additionally, DNA is typically encountered in a double-stranded form, with each strand
being oriented in an anti-parallel fashion. The two strands are complementary to one
another with each type of base on one strand forming a bond with only one type of base
on the other strand (22). The bonding, termed base-pairing, between the individual DNA
nucleobases is through hydrogen bonding (Figure 2.5). Base-pairing typically occurs
between purines and pyrimidines resulting in the normal Watson-Crick base-pairs.
Ribonucleic Acid
Ribonucleic acid, or RNA, consists of a ribose sugar ring with three separate
components attached to the sugar ring (Figure 2.2B). These include a 3’ hydroxyl group,
a heterocyclic nucleobase, and a 5’ phosphate group (22) Similar to DNA, RNA can be
differentiated into four distinct nucleotides by the identity of the heterocyclic nucleobase.
These include purines and pyrimidines (22). RNA differs from DNA, however, in that the
2’ position of the ribose sugar is a hydroxyl group (Figure 2.2B). Additionally, the
nucleobase identity is changed from uracil (U) instead of thymine (T), which differs in
that a methyl group is replaced by hydrogen within the nitrogenous ring of thymine
(Figure 2.3). Lastly, RNA is typically encountered in a single-stranded form having
directionality in the 5’ to 3’ direction.

6

That RNA is typically encountered in a single-stranded form renders RNA
capable of forming complex three-dimensional structures. RNA folding results in basepairing between complementary regions within the RNA itself. These base-paired regions
make-up the secondary, and in some cases tertiary, structures encountered for RNA.
Examples of a few of the secondary structural elements that can be encountered for RNA
species include duplexes, hairpins, bulges, loops, and junctions (Figure 2.6). These
secondary structures, which contribute to the final tertiary structure, result in the complex
shapes that RNA can acquire to perform various functions in vivo, including catalysis.
Catalytic RNA
Until the early 1980’s, protein enzymes were thought to be the only biological
species capable of performing enzymatic reactions. In 1982, an RNA species was
demonstrated to be capable of catalyzing the cleavage-ligation of phosphodiester bonds
in the absence of proteins (1). In this case, the intervening sequence within the large
ribosomal RNA (rRNA) subunit of Tetrahymena thermophila was found to act as a
catalyst. The autoexcision reaction, catalyzed by these introns, was later termed the selfsplicing reaction. Simultaneously, the active site of ribonuclease P, isolated from
Escherichia coli and Bacillus subtilis, was determined to be composed of RNA (2).
Since the discovery of catalytic RNAs, also called ribozymes, several catalytic RNA
species have been discovered. These include the hammerhead (23), hairpin (24), hepatitis
delta virus (25), Varkud satellite (26), group I and group II introns (1, 27-29),
ribonuclease P (2), and most recently the glmS ribozyme (30).
RNA Splicing
For some prokaryotic and eukaryotic cells, exon sequences are interrupted by an
intervening sequence (IVS), or intron. Prior to the formation of a mature RNA species,
the intron sequence is excised from within their flanking exon sequences. Currently, four
major classes of introns have been described based upon their mechanism of excision (31,
32). These include group I and group II introns, tRNA introns, and the spliceosomal
introns found within nuclear pre-mRNA (31, 32). For many group I and group II introns,
the introns themselves catalyze their own excision through separate self-splicing reaction
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pathways (31, 32). Note, for other group I and group II introns, proteins are required to
facilitate their splicing (1, 33). As for tRNA introns, the introns are excised through
enzymatic cleavage and ligation of the precursor RNA (31, 32). In the case of
spliceosomal introns, the intron is excised through the complex machinery of the
spliceosome (34).
Group I Introns
Group I introns have been found in the precursor mRNA, tRNA, and rRNA
transcripts in a variety of different cell types, including prokaryotes, yeast, fungi, and
viruses (3, 35). To date, more than 2000 group I introns are known (35). They range in
size from a few hundred nucleotides to approximately 3000 nucleotides (35). In general,
group I introns are composed of a common core of secondary structures, consisting of 10
to 17 base-paired regions termed P1-P17 (38-39). Upon folding, these base-paired
regions constitute the active form of the intron (Figure 2.7).
Specific regions within group I introns are employed for binding and alignment of
substrates (5’ and 3’ exon sequences) and cofactors used during the self-splicing reaction.
Molecular recognition elements (REs) are employed to bind the substrates for the
subsequent self-splicing reaction. The 5’ exon region is bound through recognition
element 1 (RE1) to form the P1 helix (40-42) (Figure 2.8). The 3’ exon region is bound
through recognition element 3 (RE3) to form helix P10 (40). The intron binds itself
intramolecularly through recognition element 2 (RE2) to form the P9.0 helix (43, 44).
Note the nucleotides that encompass RE1 and RE3, which are part of the P1 and P10
helices, are termed the internal guide sequence (IGS), in some instances. A specific
region, within the P7 region of the intron, termed the guanosine-binding site (GBS) binds
the two consecutive guanosine residues used in the self-splicing reaction (see section
titled The Self-Splicing Reaction) (45-47).
Specific reaction sites within the exon and intron sequences define the positions
of splicing, termed splice sites. For the self-splicing reaction, two splice sites (the 5’ and
3’ splice sites) determine the location where the two consecutive transesterification
reactions of the self-splicing reaction occur. The 5’ splice site is defined as the
phosphodiester backbone that is 3’ to the last nucleotide of the 5’ exon (Figure 2.8). A
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uridine residue is typically (cytosine being the only exception) the last nucleotide of the
5’ exon and forms a wobble base-pair (G•U) to a conserved guanosine within RE1 of the
intron (48-53). The 3’ splice site is defined as the phosphodiester backbone 3’ to a
conserved guanosine residue located at the 3’ terminal position of the intron, termed ωG.
Group I introns are also metalloenzymes in that they require metal ions to
facilitate the proper folding of the intron into its active form (54-56). In addition, metal
ions have been implicated in aiding in the individual steps of the self-splicing reaction.
Divalent metal ions, especially magnesium (Mg2+), are the preferred ion. Monovalent
metal ions, including sodium (Na+) or potassium (K+), are acceptable, albeit at higher
concentrations (54-56).
The Self-Splicing Reaction
The self-splicing reaction consists of two consecutive transesterification reactions,
ultimately resulting in the excision of the intron and ligation of the flanking 5’ and 3’
exons. In the first reaction step, termed substrate cleavage, the intron binds an exogenous
guanosine cofactor into the GBS (Figure 2.9A) (57). This exogenous guanosine can be
any of the 5’ phosphorylated derivatives of guanosine triphosphate (GMP, GDP, or
GTP). The 3’ hydroxyl group of the guanosine performs a nucleophilic attack upon the 5’
splice site, resulting in cleavage of the phosphodiester backbone between the 3’-end of
the 5’ exon and the 5’-end of the intron. The direct result of substrate cleavage is the
covalent attachment of the exogenous guanosine to the 5’-end of the intron (Figure 2.9A)
(11, 58).
Prior to the second step of the self-splicing reaction (exon ligation), a proposed
conformational change occurs, resulting in the expulsion of the exogenous guanosine
cofactor from the GBS (46, 47, 59). This conformational change facilitates the
preferential binding of ωG of the intron. The alignment of ωG into the GBS is
accomplished by formation of both the P10 and P9.0 helices (60-66). For the exon
ligation reaction step, the newly formed 3’ hydroxyl group of the uridine at the 3’-end of
the 5’ exon performs a nucleophilic attack upon the 3’ splice site of the intron, resulting
in the ligation of the 5’ and 3’ exons (Figure 2.9A).
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The final excised intron product, termed the linear intervening sequence, or LIVS, can undergo subsequent cyclization reactions that result in the intron self-processing
itself into a circular form (67-70). In the cyclization reaction, the L-IVS binds a portion
of the 5’-end of the intron through RE1 to form a P1 helix, resulting in the establishment
of a new 5’ splice site (Figure 2.9B). The L-IVS catalyzes an intramolecular
transesterification reaction, resulting in the covalent attachment of the 5’ and 3’-ends of
the L-IVS. The intramolecular transesterification reaction is catalyzed by the 3’ terminal
guanosine, ωG, of the L-IVS. Overall, the reaction results in a circularized intron product,
termed the circular intervening sequence, or C-IVS (Figure 2.9B).
Group I Intron-Derived Ribozymes
To further elucidate the overall mechanism of the self-splicing reaction, group I
introns have been modified by removal of their native 5’ and 3’ exon sequences (Figure
2.9). The new catalytic RNA species, known as group I intron-derived ribozymes, were
designed so that the individual steps of the self-splicing reaction could be investigated. Of
these group I intron-derived ribozymes, the Tetrahymena thermophila ribozyme (71) has
been the most extensively studied of these ribozymes. Other group I intron-derived
ribozymes, however, have been constructed. These include the intron-derived ribozymes
from Anabaena (72), Azoarcus (73), Candida albicans (74), and Pneumocystis carinii
(75). Group I intron-derived ribozymes have been shown to be capable of reaction rate
enhancements similar to enzyme catalysts and are capable of multiple-turnover reactions
(71-74).
Group I intron-derived ribozymes have been shown to be capable of catalyzing
additional non-native reactions, including ribonuclease (14, 15), phosphatase (13),
polymerization (76, 77), recombination (78), reverse-splicing (79, 80), trans-splicing (8190), trans excision-splicing (8), trans insertion-splicing (10), and 5’ replacement reactions
(91). That group I intron-derived ribozyme can catalyze additional reactions demonstrates
the multi-faceted nature of these catalysts.
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The Trans Excision-Splicing Reaction
The trans excision-splicing (TES) reaction, catalyzed by a group I intron-derived
ribozyme from the opportunistic pathogen Pneumocystis carinii, was developed to
sequence specifically excise a targeted sequence from within an RNA substrate (Figure
2.10) (8). The TES reaction consists of two consecutive transesterification reactions that
are similar to those of the self-splicing reaction. These consist of substrate cleavage
followed by exon ligation. The TES reaction has previously been shown to be capable of
excising as little as one nucleotide and as many as twenty-eight nucleotides from within
RNA substrates (8). Most recently, the TES reaction was shown to be an effective
strategy for the manipulation of RNA transcripts in vivo utilizing an Escherichia coli
model system (9).
As seen for intron-catalyzed self-splicing, TES ribozymes appear to utilize the
same molecular recognition elements for orienting their substrates and intermediates
during the TES reaction. The 5’ exon region is bound through recognition element 1
(RE1) to form the P1 helix (Figure 2.10).

The 3’ exon region is bound through

recognition element 3 (RE3) to form the P10 helix. For TES reactions resulting in the
excision of more than one nucleotide, the bridge region is bound through recognition
element 2 (RE2) to form the P9.0 helix (Figure 2.10). Though previous investigations
have shown that formation of helix P10 and P9.0 are beneficial for the overall TES
reaction, neither is required (18, 19).
In the first reaction step (substrate cleavage), the Pneumocystis carinii ribozyme
mediates the cleavage of the phosphodiester backbone located at the 3’-end of the 5’ exon
region (Figure 2.10). Therefore, for TES, the 5’ splice site is determined as the 3’-end of
helix P1. Under optimal TES conditions, a G•U wobble base-pair is formed at the 5’
splice site, however, other base-pair combinations have been substituted successively
(19). These include Watson-Crick base-pairs, though decreased TES product yields were
observed (19).
For the second reaction step (exon ligation), the nucleophilic 5’ exon attacks the
phosphodiester backbone 3’ of a specific guanosine, termed ωG, within the substrate. The
ωG, which aids in defining the 3’ splice site, is defined as the border between the bridge
region and the 3’ exon region (Figure 2.10). Furthermore, previous investigations have
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shown that only a guanosine can be defined at the ω-position of the substrate (19). The
products of exon ligation consist of the final TES product (ligated 5’ and 3’ exon
sequences) and the bridge region covalently attached to the ribozyme (Figure 2.10).
The Trans Insertion-Splicing Reaction
The trans insertion-splicing (TIS) reaction, catalyzed by a group I intron-derived
ribozyme from Pneumocystis carinii, was recently developed to site-specifically insert a
targeted sequence into an RNA substrate (Figure 2.11) (10). The TIS reaction, which
utilizes two separate RNA substrates, has been proposed to proceed through three
separate chemical steps. This includes two consecutive substrate cleavage steps and a
single exon ligation step (Figure 2.11). As seen for the ribozyme-mediated TES reaction,
TIS ribozymes appear to utilize the same molecular recognition elements for orienting
their substrates and intermediates during the TIS reaction. The TIS reaction has
previously been shown to be capable of catalyzing the insertion of six nucleotides into a
separate RNA substrate (10).
In the first reaction step (substrate cleavage), the TIS donor substrate is bound
through the first three nucleotides of Recognition Element 1 (RE1) to form a partial P1
helix, termed P1i (Figure 2.11). In addition, the TIS donor substrate is bound through
Recognition Element 3 (RE3) to form a P10 helix. The 3’ terminal guanosine (G336) of
the Pneumocystis carinii ribozyme performs a nucleophilic attack upon the 5’ splice site
(Figure 2.11). The 5’ splice site is defined as the phosphodiester backbone that is 3’ to the
last nucleotide of the 5’ exon region. The result of the substrate cleavage reaction is the
covalent attachment of the insert region of the TIS donor substrate to the 3’-end of the
Pneumocystis carinii ribozyme. After the substrate cleavage reaction, the 5’ exon region
of the TIS donor substrate dissociates from the ribozyme (Figure 2.11).
Prior to the second reaction step, the ribozyme binds the 5’ exon region of the TIS
acceptor substrate through RE1 to form a new P1 helix (Figure 2.11). In the second
reaction step (substrate cleavage), the 3’ terminal guanosine of the insert region, termed
ωGi, performs a nucleophilic attack upon the new 5’ splice site (Figure 2.11). In this
case, the 5’ splice site is defined as the phosphodiester backbone that is 3’ to the last
nucleotide of the 5’ exon region. Substrate cleavage results in the covalent attachment of
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the 3’ exon region of the TIS acceptor substrate to the 3’-end of the Pneumocystis carinii
ribozyme (Figure 2.11).
Prior to the final step of the TIS reaction, a proposed conformational change
occurs, which displaces ωGi from the GBS. This results in preferential binding of G336
of the ribozyme to the GBS, which aids in defining the 3’ splice site. The alignment of
G336 into the GBS is thought to occur through reformation of helix P10. In the third
reaction step (exon ligation), the 3’ hydroxyl group of uridine performs a nucleophilic
attack upon the phosphodiester backbone 3’ to G336. This results in final TIS product
formation, including ligation of 5’ exon region to the 3’ exon region, including the
incorporation of the insert (Figure 2.11).

Copyright © Perry Patrick Dotson II 2008
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Figure 2.1. The central dogma of molecular biology. Deoxyribonucleic acids, or DNA,
are the biological macromolecule that contain all the genetic information of a cell, and is
typically found in a double helical form. Prior to cell replication, DNA is replicated so
that an identical copy of the parental DNA is passed to each successive generation. The
genetic information stored in DNA is first transcribed to ribonucleic acids, or RNA, and
is then translated to protein. Additionally, RNA can be used as a template for the creation
of DNA through reverse transcription.
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hydroxyl, and phosphate groups. Ribonucleotides differ from their deoxyribonucleotide
counterparts in that a hydroxyl group is substituted at the 2’ position of the sugar ring.
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15

Purines

Pyrimidines

N
N

H

N

N

O

H

N
N
H

Thymine (T)

Uracil (U)

NH2

O

N
H

H

H

H
Adenine (A)

CH3

N

O

N

N

O

O

NH2

N
N

Guanine (G)

H
NH2

N
O

N
H
Cytosine (C)

Figure 2.3. Nucleobases encountered in DNA and RNA. The nucleobases encountered for
DNA and RNA are separated into bicyclic purines and monocyclic pyrimidines. Purines
include adenine and guanine, and pyrimidines include thymine, uracil, and cytosine.
DNA consists of the adenine, guanosine, thymine, and cytosine nucleobases. RNA
consists of adenine, guanosine, uracil, and cytosine nucleobases. The individual bases are
typically indicated with their single letter abbreviation; adenine (A), guanine (G),
thymine (T), uracil (U), and cytosine (C). DNA and RNA sequences are typically denoted
using single letter abbreviations, which represent the individual nucleotides.
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Figure 2.7. Sequence and proposed secondary structure of the Pneumocystis carinii group
I intron. The intron sequence is denoted in black upper case lettering and the exon
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(boxed) are shown whereby recognition element 1 (RE1) binds the 5’ exon forming the
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binds the two consecutive guanosines utilized for the self-splicing reaction.
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by group I introns. A. The self-splicing reaction. The group I intron is denoted by a gray
line and the 5’ and 3’ exon sequences are denoted by black lines. A black square within
the 5’ exon region denotes a uridine and a gray circle at the 3’-end of the intron denotes a
guanosine (ωG). The P1 helix is formed through base-pairing of recognition element 1
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(RE1) with the 5’ exon. The P10 helix is formed through base-pairing of recognition
element 3 (RE3) with the 3’ exon. The intron binds itself intramolecularly through
recognition element 2 (RE2) to form the P9.0 helix. The first reaction step (substrate
cleavage) is catalyzed by an exogenous guanosine cofactor. Substrate cleavage results in
covalent attachment of the guanosine to the 5’-end of the intron. The second step (exon
ligation) proceeds through attack of the uridine upon the ωG of the intron, resulting in
ligation of the flanking sequences. The resulting intron product is termed the linear
intervening sequence (L-IVS). B. The cyclization (circularization) reaction catalyzed by
the L-IVS. The L-IVS binds a portion of the 5’-end of the L-IVS (typically including the
RE3 region) to form a new P1 helix. An intramolecular transesterification reaction,
catalyzed by ωG (gray circle at 3’-end of L-IVS) occurs, resulting in the covalent
attachment of the 5’-end to the 3’-end of the L-IVS. This forms the circular intervening
sequence (C-IVS).
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Figure 2.9. Sequence and proposed secondary structure of a Pneumocystis carinii group I
intron-derived ribozyme. The primary sequence of the group I intron-derived ribozyme is
essentially identical to the group intron depicted in Figure 2.8. The difference between
the two sequences is removal of both the 5’ exon and 3’ exon sequences. In addition,
eight nucleotides are removed from the 5’-end of the intron and four nucleotides are
removed from the 3’ end of the intron. The molecular recognition elements (shown in
bold, boxed uppercase lettering) consist of recognition element 1 (RE1), recognition
element 3 (RE3), and recognition element 2 (RE2) which will be used for formation of
the P1, P10, and P9.0 helices respectively.
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Trans Excision-Splicing Reaction
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Figure 2.10. Diagram of the ribozyme-mediated trans excision-splicing reaction. The
Pneumocystis carinii ribozyme is denoted in gray lines and the 5’ and 3’ exon sequences
are denoted by black lines. The black square within the 5’ exon region denotes a uridine
and the gray circle adjacent to the 3’ exon region denotes a guanosine (ωG). The bridge
region, to be excised, is denoted as a dotted line. The P1 helix is formed through basepairing of recognition element 1 (RE1) with the 5’ exon. The P10 helix is formed through
base-pairing of recognition element 3 (RE3) with the 3’ exon. The first step (substrate
cleavage) is catalyzed by G336 (open circle at 3’-end of ribozyme) resulting in the

24

covalent attachment of the 3’-end of the substrate to the 3’-end of the ribozyme. The
second step (exon ligation) proceeds through attack of the uridine upon the ωG of the
substrate resulting in ligation of the flanking sequences. Note the ribozyme product of the
TES reaction is that ωG (of substrate) remains attached to the 3’-end of the ribozyme.
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Figure 2.11. Diagram of the ribozyme-mediated trans insertion-splicing reaction. The
Pneumocystis carinii ribozyme is denoted by gray lines and the TIS donor substrate is
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separated into blue (5’ exon) and red (insert) lines. A blue square within the TIS donor
substrate denotes a uridine and the red square at the 3’-end denotes a guanosine (ωGi).
The TIS acceptor substrate is denoted by black lines and the black square denotes a
uridine. The ribozyme recognition elements; RE1, RE2, and RE3 that form the P1, P9.0,
and P10 helices are depicted. The TIS donor substrate forms the P1i and P10 helices
through RE1 and RE3 of the ribozyme. In the first reaction step (substrate cleavage), the
3’ terminal guanosine (G336) of the ribozyme (open circle at the 3’-end of ribozyme)
performs a nucleophilic attack upon the 5’ splice site of the TIS donor substrate. This
results in the covalent attachment of the insert region of the TIS donor substrate to the 3’end of the ribozyme. The 5’ exon region of the TIS donor substrate dissociates from the
ribozyme and the TIS acceptor substrate is bound through a second P1 helix. For the
second reaction step (substrate cleavage), the ωGi (aligned by P9.0 helix formation)
performs a nucleophilic attack upon the 5’ splice site in the TIS acceptor substrate. This
results in the covalent attachment of the 3’ exon region of the TIS acceptor substrate to
the 3’-end of the ribozyme. The last reaction step (exon ligation) proceeds through the
nucleophilic attack of the uridine of the 5’ exon region of the TIS acceptor substrate upon
G336 of the ribozyme, resulting in the final TIS product.
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CHAPTER THREE-THE GROUP I INTRON-DERIVED RIBOZYME FROM
PNEUMOCYSTIS CARINII UTILIZES AN ENDOGENOUS GUANOSINE AS
THE FIRST REACTION STEP NUCLEOPHILE FOR TRANS EXCISIONSPLICING
‘Reproduced in part with permission from Biochemistry Copyright 2008 American
Chemical Society’
INTRODUCTION
The trans excision-splicing (TES) reaction, catalyzed by a group I intron-derived
ribozyme from the opportunistic pathogen Pneumocystis carinii (P. carinii), has
previously been shown to be capable of site-specifically excising targeted sequences from
within RNA substrates (8). The TES reaction, which is similar to the self-splicing
reaction, consists of two consecutive transesterification steps whereby the same
molecular recognition elements employed by other group I intron-derived ribozymes are
exploited for binding and alignment of subsequent TES substrates. One key difference
between the reactions, however, is that the self-splicing reaction utilizes an exogenous
guanosine cofactor as the substrate cleavage nucleophile (3), while TES does not (8).
In the absence of an exogenous guanosine cofactor, group I intron-derived
ribozymes can exploit two separate reaction pathways to catalyze the cleavage of their
intended RNA substrate. These include ribozyme-mediated 5’ hydrolysis or
intramolecular transesterification (Figure 3.1). It was previously postulated that the P.
carinii ribozyme could be catalyzing the substrate cleavage reaction through ribozymemediated 5’ hydrolysis (Figure 3.1A) (8). An alternative explanation is that an
endogenous nucleotide, most likely one at the 3’-end of the ribozyme (Figure 3.1B), is
the substrate cleavage nucleophile. There is precedent for both reactions (12-17).
Ribozyme-mediated hydrolysis reactions have previously been shown to occur for other
group I introns and their derived ribozymes, including the intron-derived ribozyme from
Tetrahymena thermophila (T. thermophila) (12, 16). The T. thermophila group I intron
has also been shown to be capable of catalyzing intramolecular cyclization
(transesterification) reactions utilizing the 3’ terminal guanosine of the intron as an
intramolecular nucleophile (see Figure 2.1B) (13, 15, 17).
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To further characterize the TES reaction, the first reaction step (substrate
cleavage) was investigated by following the accumulation of TES reaction intermediates
through the course of the reaction. It was found that the substrate cleavage reaction
proceeds through an intramolecular transesterification reaction pathway and is catalyzed
by the 3’ terminal guanosine, in this case G336, of the P. carinii (rPC) ribozyme (Figure
3.2). The intramolecular transesterification reaction pathway is supported by several lines
of evidence including the observation that the identity of the 3’ terminal nucleotide is
critical for optimal TES activity and the size and identity of ribozyme reaction
intermediates isolated from TES reactions (both in vitro and in vivo). Additionally, in
vivo results demonstrate that the reactive 3’ terminal guanosine can be created through
self-truncation of the ribozyme transcript, most likely through ribozyme-mediated 3’
hydrolysis. Apparently, the ribozyme activates itself for the TES reaction in a cell. The
implications of these results demonstrate that the ribozyme itself plays a more substantial
role than previously thought in that the ribozyme itself is an intermediate in the TES
reaction pathway.
MATERIALS AND METHODS
Oligonucleotide Synthesis and Preparation
DNA oligonucleotides were obtained from Integrated DNA Technologies
(Coralville, IA) and were used without further purification. RNA oligonucleotides were
obtained from Dharmacon Research, Inc. (Lafayette, CO) and were deprotected using the
manufacturer’s suggested protocol. Concentrations of individual oligonucleotides were
calculated

from

UV

absorption

measurements

using

a

Beckman

DU

650

spectrophotometer (Beckman Coulter, Inc.; Fullerton, CA). RNA oligonucleotides were
5’-end radiolabeled by phosphorylation of the 5’ terminal hydroxyl group with [γ-32P]
ATP (Amersham Pharmacia Biotech; Piscataway, NJ) using T4 polynucleotide kinase
(New England Biolabs; Beverly, MA) as previously described (75). RNA
oligonucleotides were 3’-end radiolabeled by ligation of 5’-end radiolabeled pCp (5’*pCp) to the 3’-end of the RNA oligonucleotide using T4 RNA ligase (New England
Biolabs) as previously described (10). Note that the 3’-end radiolabeling strategy will
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result in substrates being a nucleotide longer than 5’-end radiolabeled substrates.
Ribozyme Synthesis and Preparation
Two ribozymes were constructed via run-off transcription of linearized plasmids.
For both cases, the P. carinii ribozyme plasmid, PC, was linearized in a 50 μL reaction
consisting of 16 μg plasmid, 5 μL of 10X REACT 2 buffer (Invitrogen; Grand Island,
NY), and 50 units of either XbaI (to form PC-X) or HindIII (to form PC-H) at 37 °C for 2
h. The linearized plasmids were purified using a QIAquick PCR purification kit (Qiagen;
Valencia, CA).
Two additional ribozymes were constructed via PCR using the PC plasmid as the
template. The following primers were used for the individual ribozyme constructs: the
forward

PCR

primer

for

both

ribozyme

constructs

was

5’

CTCTAATACGACTCACTATAGAGGG3’, and the reverse PCR primers (variable

regions

are

underlined)

for

each

of

5’

TTAGATATACTCTTTCTTTCGAAAGAGG

3’

the
for

ribozyme

constructs

were

(10),

and

PC-ωA

5’

CTAGATATACTCTTTCTTTCGAAAGAGG3’ for PC-ωG. All PCR reactions utilized

45 pmol of each primer in a reaction consisting of 100 ng PC plasmid, 1 unit of Pfu DNA
polymerase (Stratagene; La Jolla, CA), 1X Pfu reaction buffer (Stratagene), and 0.5 μM
dNTPs. The PCR conditions were 95 °C for 30 s (initial denaturation), followed by 40
cycles of 95 °C for 30 s (denaturation), 55 °C for 45 s (annealing), and 68 °C for 120 s
(elongation). A final elongation step of 68 °C for 360 s was performed after the final
cycle. PCR products were separated on a 2% agarose gel and were purified using the
QIAquick Gel Extraction Kit (Qiagen) using the manufacturers protocol.
Both the linearized and PCR amplified DNA templates were used for run-off
transcription in a 50 μL reaction consisting of 1 μg DNA template, 50 units of T7 RNA
polymerase (New England Biolabs), 40 mM Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM
DTT, 5 mM spermidine, and 1 mM rNTP mix for 2 h at 37 °C. Each of the individual
ribozyme constructs were purified using a Qiagen Plasmid Midi Kit (Qiagen), as
previously described (8).
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TES Reactions
TES reactions were conducted at 44 °C in H10Mg buffer consisting of 50 mM
HEPES (25 mM Na+), 135 mM KCl, and 10 mM MgCl2. Prior to each reaction, 200 nM
ribozyme in 25 μL H10Mg buffer was preannealed at 60 °C for 5 min and then slow
cooled to 44 °C. The reaction was initiated by adding 5 μL of a 10 nM solution of
radiolabeled substrate (also in H10Mg solution). The final concentrations of the ribozyme
and substrate in the reaction mixtures were 166 nM and 1.3 nM respectively. Time course
studies were conducted by the periodic removal of 3 μL aliquots, which were then
quenched by adding an equal volume of 2 X stop buffer (10 M urea, 3 mM EDTA, and
0.1 X TBE). The products and substrates were denatured at 90 °C for 1 min and then
separated on a 12.5% denaturing polyacrylamide gel. Gels were dried under vacuum and
the bands were visualized on a Molecular Dynamics Storm 860 Phosphoimager. The
observed rate constant, kobs, was obtained from a plot of the percent substrate cleavage
product (substrate cleavage plus TES product) over time (8). Note the kobs values
obtained are reported as lower limit values, in some instances, and cannot be taken as
precise values due to the limits of manual pipetting.
RT-PCR Amplification of TES Reaction Intermediates In Vitro
TES

reactions

were

conducted

using

a

20-mer

(5’AUGACUACUCUCGUGCUCUU3’) substrate using the conditions described above.
The
5’

products

were

amplified

via

GAGGGTCATGAAAGCGGCGTG3’

RT-PCR
(specific

with
for

the

the

following

rPC

primers:

ribozyme)

and

5’

GCACCGGTAAGAGCACGAGAG3’ (specific for the bridge-3’ exon). RT-PCR

reactions were conducted using an Access RT-PCR kit (Promega; Madison, WI) and
consisted of a 50 μL reaction containing approximately 2 μL TES reaction (166 nM
ribozyme), 1 mM MgSO4, 45 pmol of each primer, 0.2 mM dNTPs, 5 units AMV reverse
transcriptase, and 5 units Tfl DNA polymerase. The reactions were subjected to first
strand synthesis at 45 °C for 45 min, which was followed by 2 min at 94 °C for
deactivation of the AMV reverse transcriptase. The reactions were then subjected to 40
PCR cycles consisting of 94 °C for 30 s (denaturation), 55 °C for 60 s (annealing), and 68
°C for 120 s (elongation). After the cycling was complete, a final elongation step of 68
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°C for 10 min was performed. The RT-PCR products were separated on a 2% agarose gel
and excised from the gel matrix using the QIAquick Gel Extraction Kit (Qiagen). The
excised products were ligated into the pDrive cloning vector (Qiagen) using the
manufacturer’s recommended protocol and transformed into DH5α cells (Invitrogen).
Colonies were picked and sequenced for identification (Davis Sequencing; Davis, CA).
In Vivo Characterization of TES Intermediates
Plasmids were used that contain both the ribozyme and GFP target transcript. In
all cases, plasmids were transformed into Escherichia coli (E. coli) strain JM109 (DE3),
which encodes T7 RNA polymerase, as described (9). Once transformed, T7 RNA
polymerase was induced by induction with isopropylthiogalactoside (IPTG), which
resulted in the transcription of both the ribozyme and GFP, as described (9). The
plasmids: pQBI-Mut-GFP+p3x-RE3 (5) (active ribozyme with mutant GFP) and pQBIMut-GFP+p3x-RE3 (5)-ΔGBS (inactive ribozyme with mutant GFP) were used (9). After
transformation and induction, 1.5 mL of the designated cell culture was used for total
RNA isolation using the Ambion RiboPureTM-Bacteria Kit (Ambion; Austin, TX). The
TES reaction intermediate was amplified via RT-PCR using the following primers:
5’

GTGGAGAGGTAGAAAGCGGCGTG3’ (specific for P. carinii ribozyme) and

5’

CCATGCCATGTGTAATCCCAGCAGC3’ (specific for 3’-end of GFP transcript),

which amplify products containing only both the ribozyme and the GFP transcript. RTPCR reactions were conducted using the Access RT-PCR system (Promega) consisting of
a 50 μL reaction containing approximately 1 μg total RNA, 1 mM MgSO4, 45 pmol of
each primer, 0.2 mM dNTPs, 5 units AMV reverse transcriptase, and 5 units Tfl DNA
polymerase. Reactions were then subjected to first strand synthesis (45 °C for 45 min),
which was followed by 2 min at 94 °C for deactivation of the AMV reverse transcriptase.
These reactions were then subjected to 40 PCR cycles consisting of 94 °C for 30 s
(denaturation), 55 °C for 60 s (annealing), and 68 °C for 120 s (elongation). After the
cycling was complete a final extension step of 68 °C for 10 min was performed. The RTPCR products were separated on a 2% agarose gel and were excised from the gel matrix
using the QIAquick Gel Extraction Kit (Qiagen). The excised products were ligated into a
pDrive cloning vector (Qiagen) using the manufacturer’s recommended protocol and
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transformed into DH5α cells (Invitrogen). Colonies were picked and sequenced (Davis
Sequencing) for identification.
RESULTS
TES Reaction Intermediates In Vitro
The two possible substrate cleavage reaction mechanisms, ribozyme-mediated 5’
hydrolysis or intramolecular transesterification cleavage, can be distinguished by
following the reaction intermediates for TES reactions conducted in vitro (Figure 3.1).
For TES reactions conducted with the substrate, 5’AUGACUGCUC3’, the 5’ hydrolysis
mediated reaction will result in two reaction intermediates consisting of the 5’-exon
(5’AUGACU3’) and bridge-3’ exon (5’GCUC3’) (Figure 3.1A). In contrast, the
intramolecular transesterification reaction will result in two reaction intermediates
consisting of the 5’-exon (5’AUGACU3’) and the bridge-3’-exon being covalently
attached to the 3’-end of the rPC ribozyme (5’rPC-GCUC3’) (Figure 3.1B). However,
there is no size difference between the 5’-exon sequences, which precludes
discriminating the two cleavage pathways using 5’-end radiolabeled substrate. Using a
3’-end radiolabeled substrate, however, could potentially distinguish if the bridge-3’exon is separate from the ribozyme or if it is being attached to the 3’-end of the ribozyme.
Therefore, we synthesized the 3’-end radiolabeled substrate (5’AUGACUGCUCC3’ italic
lettering denotes the nucleotide to be excised and underlined lettering denotes the
additional nucleotide due to 3’-end radiolabeling) and followed the formation of the
intermediate and product during the normal course of the TES reaction.
TES reactions were conducted under previously optimized reaction conditions (8)
using both 3’ and 5’-end radiolabeled substrates for comparison (Figure 3.3, lanes G-J).
The results of reaction time course studies (Figures 3.5) show that TES products are
formed in approximately 70% yield (73 ± 1.8% and 69 ± 3.3%), regardless of which end
of the substrate is radiolabeled. Because of the limitations of hand mixing relatively fast
reactions, the only quantification that can be made of observed rate constants, kobs, is a
lower limit of >8 min-1 for the 3’ labeled substrate (Figure 3.5A) and >6 min-1 for the 5’
labeled substrate (Figure 3.5B) for the first step of the TES reaction. More importantly,
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however, when using 3’-end radiolabeled substrate, essentially all radiolabeled
intermediate is a high molecular weight band (12 ± 0.3% and 11 ± 1.6%) that
corresponds to the predicted 341 nucleotide intermediate expected for the intramolecular
transesterification mechanism. This is not consistent with the hydrolysis mechanism.
In addition, TES reactions were conducted with the 3’-end radiolabeled substrate,
10-mer-dG, 5’AUGACUdGCUC3’, which is predicted to prevent the second step of the
TES reaction (exon ligation) and should accumulate only first step product (Figure 3.4).
TES reactions conducted with the 10-mer-dG substrate shows that the high molecular
weight intermediate is now produced in yields of 87 ± 0.4% (Figure 3.5C). This is a
further indication that the high molecular weight band is the reaction intermediate, and
suggests that the TES reaction proceeds through the intramolecular transesterification
mechanism. Again, the only quantification that can be made of the observed rate
constant, kobs, for the first step of this TES reaction is a lower limit of >6 min-1.
For confirmation of the identity of TES reaction intermediates, RT-PCR was
employed to amplify the high molecular weight intermediates for subsequent sequencing
(Figure 3.6). For these studies a 20-mer substrate, 5’AUGACUACUCUCGUGCUCUU3’,
was used to facilitate RT-PCR amplification. Our results from sequencing five reaction
products show that the TES reaction does produce the intermediate expected for the
intramolecular transesterification reaction, whereby the 3’-end of the substrate
(5’ACUCUCGUGCUCUU3’) attaches to the terminal nucleotide (G336) of the ribozyme
(Figure 3.7A).
TES Reactions Using Terminal-Modified Ribozymes
A defining characteristic of the intramolecular transesterification cleavage
reaction is that the ribozyme will utilize a terminal guanosine as an intramolecular
nucleophile and that it must bind to the guanosine-binding site (GBS), which
preferentially binds guanosine. To test if only guanosine can be utilized as the
intramolecular nucleophile, PCR templates were used to synthesize two new ribozyme
constructs, one ending in guanosine (rPC-ωG) and one ending in adenosine (rPC-ωA). If
only a 3’ terminal guanosine can be used, then only rPC-ωG will be active; rPC-ωA will
produce neither product nor intermediate. TES reactions were conducted using the same
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reaction conditions as for the rPC ribozyme (Figure 3.3, lanes K-R). The results show
that both ribozymes produced intermediate and product with approximately the same
amount of product being formed (80 ± 1.5% versus 76 ± 2.2%). The terminal adenosine,
however, results in a slower reaction (kobs = 0.14 ± 0.02 min-1) than that with the terminal
guanosine (kobs = 2.6 ± 0.09 min-1) (Figure 3.8). Nevertheless, the identity of the 3’
terminal end of the ribozyme does affect TES reaction kinetics, as expected only for the
intramolecular transesterification mechanism.
The observation that the rPC-ωA ribozyme produces both intermediate and
product can be explained through two different scenarios. In the first, the non-encoded
addition of nucleotides to the 3’-end of RNA transcripts could potentially lead to
guanosines being added to the 3’-end of the ribozyme, which has previously been shown
to be a consequence of run-off transcription utilizing T7 RNA polymerase (92, 93). For
the second, a 3’ terminal adenosine could potentially be used as an intramolecular
nucleophile. This in fact has previously been demonstrated for a T. thermophila ribozyme
construct that predominately terminates in an adenosine (94). The RT-PCR strategy
described above was employed to isolate and sequence the TES ribozyme intermediate
from TES reactions conducted with rPC-ωA ribozyme. Results show that the terminal
adenosine is the nucleophile in these reactions (Figure 3.7B). Apparently, the
intramolecular transesterification reaction can be catalyzed by a terminal guanosine or
adenosine. That guanosine is ~20-fold more effective (Figure 3.8) is likely related to the
fact that guanosine is expected to have enhanced affinity for the guanosine binding site
(GBS) of the ribozyme.
Identification of TES Reaction Intermediates In Vivo
We have previously shown that TES ribozymes can be used for the excision of
RNA sequences from within mRNA transcripts utilizing an E. coli model system (9).
Briefly, a ribozyme was developed to sequence-specifically excise an internal point
mutation from within a green fluorescent protein (GFP) transcript, thus repairing the
mutant transcript and creating fluorescent cells (9). It was of interest, therefore, to
determine if the intramolecular transesterification mechanism is occurring in vivo; and if
so, how the ribozyme obtains the reactive 3’ terminal nucleotide. To express the GFP-
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specific ribozyme (termed rPC-GFP) in vivo, the ribozyme sequence was flanked by a T7
RNA polymerase promoter and terminator for proper initiation and termination of
transcription (95). Although the terminator sequence has previously been shown to
predominately end in guanosine, shown in Figure (3.9), it was not known if this
guanosine was acting as an intramolecular nucleophile for the TES reaction (96).
TES reactions were conducted in vivo under previously described methods (9).
Total RNA isolated from in vivo experiments were subjected to RT-PCR reactions using
primers designed to bind the 5’-end of the rPC-GFP ribozyme and the 3’-end of the GFP
resulting in the amplification of only the TES reaction intermediate, if present (Figure
3.10 and 3.11). A single product was amplified by RT-PCR reactions which were ligated
into a cloning vector and subsequently sequenced for the presence of the TES reaction
intermediate. Sequence analysis of 17 cloned RT-PCR products showed that the 3’-end of
the GFP transcript was covalently attached to the 3’-end of the rPC-GFP ribozyme (Table
3.1). Additionally, in 11 of these cases, the ribozyme was covalently attached to the
expected site on the target (U607; 5’-UACCUU607-3’) (Table 3.1). However, in 6 of these
cases, the ribozyme was attached to a similar, but distinct site (U624; 5’-GCCCUU624-3’)
(Table 3.1). Apparently, the sequence-specificity of this particular ribozyme construct is
not especially high for cleavage at its intended target. Nevertheless, finding the TES
ribozyme intermediate strongly suggests that the intramolecular transesterification
mechanism also occurs in vivo.
Surprisingly, in 16 of the 17 cases the T7 terminator sequence was not present at
the 3’-end of the ribozyme (Figure 3.9), which suggests that it was somehow removed in
vivo prior to the ribozyme becoming functional (Table 3.1). For the other case, a small
portion of the T7 terminator sequence was present at the 3’-end of the ribozyme. In 16
sequences the active ribozyme ended with the natural terminal nucleotide of the ribozyme
(G336), and in 1 case it ended with a guanosine 4 bases downstream (G340) (Figure 3.9).
It is likely that these terminal guanosines are being created through a ribozyme-mediated
intramolecular 3’ hydrolysis reaction, which is well known to occur in vitro (13, 15, 17,
68, 69, 97). If true, the ribozyme is catalyzing its own activation prior to catalyzing the
TES reaction. Taken together, these results strongly support a mechanism where a
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ribozyme 3’ terminal guanosine is the substrate cleavage nucleophile in the TES reaction,
both in vitro and in vivo.
3’ Hydrolysis Can Activate the Ribozyme for the Intramolecular Transesterification
Reaction
In order to test whether TES ribozymes can generate 3’ terminal guanosines via 3’
hydrolysis, the TES and RT-PCR procedures were conducted in vitro using a ribozyme
construct containing an elongated 3’-end. The ribozyme, termed rPC-HindIII was created
by linearizing the PC plasmid with HindIII (instead of XbaI), which linearizes the
plasmid seven bases downstream of G336. TES reactions conducted in vitro using 5’ and
3’-end radiolabeled 10-mer substrates resulted in the formation of the expected
intermediates and products (Figure 3.3, lanes S-V), showing the construct is still active
even though it was synthesized to be longer than necessary. Sequence analysis (total of
five sequences) of the TES ribozyme intermediate showed that the expected
intramolecular transesterification intermediate is found, including that it ends in G336.
Apparently, the extra seven bases were removed in vitro, thus activating G336 for
subsequent TES reactivity, as expected.
DISCUSSION
TES Reaction Mechanism
In this study, it was determined that the identity of the 3’ terminal nucleotide of
the P. carinii ribozyme is important for effective catalysis of the substrate cleavage
reaction in TES reactions; that a 3’ guanosine is required for this reactivity; that substrate
cleavage is not significantly driven by ribozyme-mediated hydrolysis; that the 3’ half of
the target transcript is covalently attached to the 3’ terminal guanosine of the ribozyme in
the intermediate step of the TES reaction; and that this mechanism is occurring in vitro
and in vivo. These results are compiled into the reaction mechanism shown in Figure 3.1.
These results suggest the following reaction mechanism for the first step of the
TES reaction. First, the ribozyme binds the target transcript via the RE1 molecular
recognition component, resulting in the formation of helix P1. The site of first step
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reactivity (substrate cleavage) is thus determined as the 3’-end of helix P1, usually
characterized by a G•U wobble base-pair (48, 49). The 3’ terminal guanosine (in this
case G336) appears to bind to the catalytic core of the ribozyme via the GBS, hence the
preference for a 3’ terminal guanosine, aided presumably by P9.0 helix formation. This
conformationally orients the 3’ hydroxyl group of the ribozyme for nucleophilic attack at
the phosphodiester backbone of the substrate cleavage site. The result of this substrate
cleavage reaction step is that the 3’ half of the target transcript becomes covalently
attached to the ribozyme. Concurrently, the 5’ half of the target transcript remains bound
to the ribozyme through secondary and tertiary interactions via helix P1.
The second reaction step of the TES reaction, called exon-ligation, is catalyzed by
the free 3’ hydroxyl group in helix P1, which is typically a uridine (48, 49). This
nucleophile attacks the phosphodiester backbone upstream and adjacent to the target
transcript guanosine now in the GBS, resulting in the formation of a normal
phosphodiester bond between the regions flanking the excised segment. As occurs in selfsplicing (46, 47, 59), a local conformation change in the ribozyme occurs, prior to exon
ligation, which results in the sequential rearrangement of guanosines in the GBS. The 3’
terminal guanosine of the ribozyme is replaced by the 3’ guanosine of the target’s excised
segment. The overall reaction, then, has the excised segment being removed from the
target transcript.
TES Reaction In Vivo
The results demonstrate that the intramolecular transesterification cleavage
mechanism is also occurring when the TES reaction takes place in E. coli. Sequencing of
reaction products indicate that the same reaction intermediates are generated in vivo as in
vitro. Moreover, it was discovered that, in a cell, the ribozyme becomes truncated at its
3’-end, resulting in the creation of an active 3’ terminal guanosine at the 3’-end of the
ribozyme (Figure 3.9). It is likely that this truncation is catalyzed by the ribozyme itself,
and that the mechanism is site-specific 3’ hydrolysis (13, 15, 17, 68, 69, 97). In addition,
sequencing of TES reaction intermediates demonstrates that the ribozyme targets two
similar sites on the GFP transcript (out of hundreds of possible sites), with the desired site
being targeted 65% of the time. Previous studies using the P. carinii ribozyme have
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shown that stable base-pairing between the substrate and the first four nucleotides of the
ribozymes RE1 region (to form a functional P1 helix) is primarily responsible for the
molecular recognition components that bind the substrate to the ribozyme (98). It is not
surprising, then, to find that both the major and minor target sites are able to form this
four nucleotide helix, which accounts for their similar reactivities. Taken together, the in
vivo reaction demonstrates that the TES is following an intramolecular transesterification
cleavage mechanism, the ribozyme is self-activating, and the reaction is only moderately
sequence-specific.
The 3’ Terminal Adenosine Ribozyme and Role of Molecular Recognition
Results demonstrate that the P. carinii ribozyme can utilize a 3’ terminal
adenosine (A336) as the intramolecular transesterification nucleophile. Presumably, the
terminal adenosine binds to the GBS of the ribozyme, which is known to preferentially
bind guanosine (57). Studies using a T. thermophila ribozyme, however, suggest that
adenosine can bind the GBS with the help of non GBS interactions (94). The most likely
interaction is the formation of helix P9.0 (Figure 3.1B), which participates in the
alignment of the 3’ splice site of group I introns into the GBS (60-66). It seems for the
TES reaction, the role of P9.0 helix formation could be multifaceted in that it helps to
align the terminal nucleotide of the ribozyme into the GBS prior to the intramolecular
transesterification reaction, and also aligns the substrate guanosine (the guanosine to be
excised) into the GBS for the subsequent exon-ligation reaction (Figure 3.1B).
Comparison with Previous Results
That the 3’ terminal guanosine of group I intron-derived ribozymes can be a
nucleophile has previously been reported, although not in the context of the TES reaction.
The terminal guanosine of the T. thermophila group I intron-derived ribozyme has been
implicated in ribonuclease (15), phosphotransferase (13), and phosphatase (13) activities
in vitro. In these reactions, the ribozymes 3’ terminal guanosine was obtained through
site-specific 3’ hydrolysis, which exploited high temperature ribozyme pre-incubations
under alkaline conditions (15, 17, 68, 69). We found that production of active rPC
ribozyme in vitro does not require this pre-incubation, although 3’ hydrolysis might still
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be occurring, albeit at prevailing reaction conditions. The T. thermophila intron also
utilizes a 3’ terminal guanosine for catalyzing the reverse splicing reaction (79, 80), in
which the intron becomes imbedded into cellular transcripts as well as in vitro cyclization
reactions (67-70). Other group I ribozymes have exploited their 3’ terminal guanosines
for polymerization (76, 77) and recombination (78) reactions. Apparently, 3’ terminal
guanosines of group I intron-derived ribozymes can be involved in many natural and
unnatural reactions.
Group I intron-derived ribozymes have additionally been exploited for catalyzing
reactions where a 3’ terminal guanosine is not required. In these instances, an exogenous
guanosine cofactor is usually the first (or only) reaction step nucleophile. For example,
group I intron-derived ribozymes have been used to replace terminal (81-90) segments of
RNA transcripts, resulting in the repair of mutant transcripts. Apparently, group I intronderived ribozymes can catalyze a wide variety of reactions, which demonstrates their
versatility in both catalysis and molecular recognition.
Design Principles for the P. carinii Ribozyme In Vivo
Synthesizing RNAs that contain specific terminal sequences is challenging
because RNA polymerases tend to add non-templated nucleotides onto the ends of RNA
transcripts (92, 93). One common strategy is to use a small self-cleaving ribozyme to
truncate the elongated target transcript at the desired site (72, 99). Unfortunately, this
method is invasive and creates a 2’, 3’ cyclic phosphate, which would eliminate TES
reactivity, though the 2’, 3’ cyclic phosphate could subsequently be removed by
dephosphorylation to render the active form of the ribozyme. Fortunately, at least in E.
coli (and confirmed in vitro), TES ribozymes appear to self-catalyze their own truncation,
thus creating a functional 3’ terminal guanosine. The efficiency with which the 3’
hydrolysis reaction occurs with the rPC ribozyme, however, has not yet been determined
in vivo. This might be a limiting factor for TES reaction conducted in vivo. If true,
enhancing the 3’ hydrolysis reaction could enhance the yield of TES ribozymes. To this
end, it has been reported that P10 helix formation prior to the first step of the self-splicing
reaction increases the amount of 3’ hydrolysis product obtained in vitro (100). This
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design strategy could be implemented by adding sequences after G336 that are
complementary to RE3 of the ribozyme (see Figure 3.1).
In this study it was demonstrated that the ribozyme is not entirely specific for the
intended site on the target. This lack of absolute sequence-specificity was found to be
true with other group I intron-derived ribozyme-mediated reactions (82). Therefore, a
variety of strategies has been devised to ameliorate this limitation. Chief among them is a
clever strategy to add an artificial substrate binding element to a trans-splicing ribozyme
(83, 84, 86-90). This extended guide sequence (EGS) could easily be inserted at the 5’end of the ribozyme to help increase sequence specificity of TES ribozymes.
Prior to this study, no reasonable experimental strategies could be used to
determine sites within an RNA transcript that are accessible to the rPC ribozyme. Our
results, however, suggest that accessible sites can be determined by amplifying the
intermediates using RT-PCR. Intermediates will only be formed if their target sites are
accessible. This strategy could be implemented by using one primer that is specific for
the ribozyme and the other primer can be specific for the 3’-end of the transcript.
Implications for Native Group I Intron Function In Vivo
Group I introns catalyze the self-splicing reaction, wherein the introns excise
themselves (sometimes with the requirement of proteins), from RNA transcripts. It has
also been demonstrated that intact group I introns can be mobile elements by catalyzing a
reverse-splicing reaction (79, 80). We now demonstrate that essentially intact group I
introns can covalently attach themselves to RNA transcripts in trans while catalyzing the
removal of an internal segment from within RNA transcripts through TES. Apparently,
group I introns are multifaceted in vivo catalysts.

Copyright © Perry Patrick Dotson II 2008
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Table 3. 1. Analysis of ribozyme intermediates isolated from in vivo testing from JM109(DE3) cells
Test construct

RT-PCR
producta

TES intermediate
utilizing G336b

TES
intermediate
utilizing G340c

Primary site
targetedd

Alternative
site
targetede

Active ribozyme
+
94%
6%
65%
35%
+ Mutant GFP
a
Total RNA isolated from JM109 (DE3) cells were subjected to RT-PCR to amplify the ribozyme
intermediate with the 3’-end of the GFP mRNA attached to the ribozyme; (+) positive RT-PCR band.
b
Percentage of ribozyme intermediates with 3’-end of GFP mRNA attached through G336 of the
GFP-rPC ribozyme (16 of 17 RT-PCR products sequenced). c Percentage of ribozyme intermediates
with 3’-end of GFP mRNA attached through G340 of the GFP-rPC ribozyme (1 of 17 RT-PCR
products sequenced). d Percentage of RT-PCR products sequenced (11 of 17 RT-PCR products) that
indicated the GFP-rPC ribozyme targeted the primary site (U607, Codon 201). e Percentage of RTPCR products sequenced (6 of 17 RT-PCR products) that indicated the GFP-rPC ribozyme targeted
an alternative site (U624, Codon 207).
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Figure 3.1. Comparison of potential TES reaction mechanisms. The P. carinii ribozyme
is shown as a grey line and the 5’ and 3’ exons are black lines. The bridge region (the
region to be excised) is shown as a dashed gray line. The black square within the 5’ exon
represents a uridine and the gray circle adjacent to the 3’ exon represents a guanosine.
The open circle (B) at the 3’-end of the ribozyme represents the 3’ terminal nucleotide of
the ribozyme (ωG or ωA). The first step of the TES reaction proceeds through either
ribozyme-mediated
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hydrolysis

(A)

transesterification (B).
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Figure 3.2. Proposed secondary structure of the Pneumocystis carinii (rPC) ribozyme.
The rPC ribozyme is denoted in uppercase lettering. The molecular recognition elements
are denoted in bold uppercase. The potential 3’ terminal guanosine, G336, of the
ribozyme is in bold lettering.
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Figure 3.3. Representative polyacrylamide gel for TES conducted with 5’ and 3’-end
radiolabeled substrates. Polyacrylamide gel showing the substrates, intermediates, and
products of TES reactions conducted with 166 nM ribozyme and 1.33 nM substrate at 44
°C for 15 min. Lanes A, C, and E contain 5’-end radiolabeled 10-mer, 9-mer, and 6-mer
size controls. Lanes B, D, and F contain 3’-end radiolabeled 10-mer, 9-mer, and 5-mer
size controls. Note that the 3’-end radiolabeled size controls are one nucleotide larger
than 5’-end radiolabeled size controls. Gel lanes containing a plus (+) sign show reactions
conducted in H10Mg and lanes containing a minus (-) sign show reactions conducted in
H0Mg. Lanes G-J contain the normal rPC ribozyme with 5’-end radiolabeled 10-mer
(lanes G and H) or 3’-end radiolabeled 10-mer (lanes I and J). Lanes K-N contain the
rPC-ωA ribozyme with 5’-end radiolabeled 10-mer (lanes K and L) or 3’-end
radiolabeled 10-mer (lanes M and N). Lanes O-R contain the rPC-ωG ribozyme with 5’end radiolabeled 10-mer (lanes O and P) or 3’-end radiolabeled 10-mer (lanes Q and R).
Lanes S-V contain the rPC-HindIII ribozyme with 5’-end radiolabeled 10-mer (lanes S
and T) or 3’-end radiolabeled 10-mer (lanes U and V).
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Figure 3.4. Representative polyacrylamide gel for TES reactions conducted with the 10mer-dG substrate. Polyacrylamide gel showing TES substrate, intermediate, and product
of TES reactions conducted with 166 nM ribozyme, 1.33 nM substrate, H10Mg, at 44 °C
for 15 min. Lanes A, B, and C contain 3’-end radiolabeled 11-mer, 10-mer, and 5-mer
size controls, respectively. Note that 3’-end radiolabeled size controls are one nucleotide
larger than 5’-end radiolabeled size controls. Plus (+) represent TES reactions conducted
in H10Mg and minus (-) represent TES reactions conducted in H0Mg (Lane D) or
without ribozyme (Lane E). Lane F contained the normal rPC ribozyme with 3’-end
radiolabeled 10-mer. Lane G contains the normal rPC ribozyme with the 3’-end
radiolabeled 10-mer-dG substrate.
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Figure 3.5. Graphical representations of TES reactions as a function of substrate.
Reactions were conducted in duplicate with 166 nM rPC, 1.33 nM substrate, and H10Mg
at 44 °C for 15 min. A. TES reaction using 5’-end radiolabeled substrate
(AUGACUGCUCC). The 10-mer TES product (kobs >6 min-1) is represented by filled
circles, and the higher molecular weight (ribozyme) intermediate is represented by open
circles. B. TES reaction using 3’-end radiolabeled substrate (AUGACUGCUC). The 9mer TES product (kobs >8 min-1) is represented by filled circles and the 6-mer
intermediate is represented as open circles. C. TES reaction using 3’-end radiolabeled
substrate (AUGACUdGCUCC). The 10-mer TES product is represented by filled circles,
and the higher molecular weight (ribozyme) intermediate (kobs >6 min-1) is represented by
open circles. Each graph shows the average of two independent assays. Standard
deviations for each time point are less than 15%.
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Figure 3.6. Diagram of RT-PCR strategy for the amplification of TES ribozyme
intermediate. TES reactions conducted with rPC and rPC variants using the 20-mer TES
substrate (5’AUGACUACUCUCGUGCUCUU3’). Reaction with the substrate will result
in the covalent attachment of the bridge-3’ exon region (5’ACUCUCGUGCUCUU3’,
denoted as grey block) to the 3’-end of the rPC ribozyme. The bridge-3’ exon region is
used as a primer binding site for reverse transcription (RT) for first strand synthesis of the
TES ribozyme intermediate. An additional primer, specific for the 5’-end of the rPC
ribozyme, is included for the polymerase chain reaction (PCR) to amplify the TES
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ribozyme intermediate, if present. Isolated RT-PCR products are subsequently ligated
into a cloning vector and sequenced for identification of TES ribozyme intermediates.
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Table 1. Sequencing results for RT-PCR products isolated from TES reactions conducted with rPC and rPCωA ribozymes.
Ribozyme
Number of sequences
Identity of 3’ terminal
Sequence of ribozyme+ bridge(RT-PCR products)
nucleotidea
3’exonb
5’
rPC
5
G336
AG336ACUCUCGUGCUCUU 3’
5’
rPC-ωA
5
A336
AA336ACUCUCGUGCUCUU 3’
a
RT-PCR products were isolated from TES reactions conducted with either the rPC or rPC-A ribozyme
construct. Sequencing demonstrated that the 3’ terminal nucleotide was either a guanosine (G336 for rPC) or
adenosine (A336 for rPC-ωA). b Sequencing of 5 RT-PCR products demonstrated that the bridge-3’ exon
region of the 20-mer substrate (5’AUGACUACUCUCGUGCUCUU 3’) became covalently attached to the 3’
terminal nucleotide of each ribozyme.

Figure 3.7. Sequencing results for RT-PCR products isolated from TES ribozyme
intermediates. A. Representative chromatogram for sequencing result for the rPC
ribozyme. Note that the 3’-end of the substrate attaches to the terminal nucleotide (G336)
of the ribozyme. Individual nucleotides are denoted by color; guanosine (black),
adenosine (green), cytosine (blue), and thymine (red). B. Representative chromatogram
for sequencing result for the rPC-ωA ribozyme. The 3’ terminal nucleotide (A336) is
depicted in green. Note that the 3’-end of the substrate attaches to the terminal nucleotide
(A336) of the ribozyme. C. Table summarizing all five sequencing results for the rPC
and rPC-ωA ribozymes.
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Figure 3.8. Graphical representations of TES reactions as a function of ribozyme
construct. Reactions were conducted in duplicate with 166 nM ribozyme, 1.33 nM
substrate, and H10Mg at 44 °C for 15 min. A. TES reaction using the PCR-derived rPCωA ribozyme construct. The 10-mer TES product (kobs = 0.14 ± 0.02 min-1) is represented
by filled circles, and the higher molecular weight (ribozyme) intermediate is represented
by open circles. B. TES reaction using the PCR-derived rPC-ωG ribozyme construct. The
10-mer TES product (kobs = 2.6 ± 0.09 min-1) is represented by filled circles, and the
higher molecular weight (ribozyme) intermediate is represented by open circles. Each
graph shows the average of two independent assays. Standard deviations for each time
point are less than 15%.
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Figure 3.9. Sequence and proposed secondary structure of the rPC-GFP ribozyme. The
previously constructed rPC-GFP ribozyme (8) designed for in vivo model test system is
shown in uppercase lettering. The sequence and predicted structure of the T7 terminator,
which was appended onto the 3’-end of the rPC-GFP ribozyme for in vivo experiments
are highlighted. The guanosines (G336 and G340) found to act as ribozyme 3’ terminal
guanosines are denoted.
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Figure 3.10. RT-PCR strategy for isolation of the TES intermediate in vivo. The
endogenous guanosine-mediated 5’ cleavage reaction in vivo will result in the covalent
attachment of the 3’-end of the GFP mRNA to the 3’-end of the P. carinii ribozyme
(GFP-rPC) through a 3’ terminal guanosine. The TES ribozyme intermediate, if present,
will constitute a portion of the total RNA isolated from JM109 (DE3) cells (Step 1). In
step 2, the 3’-end of the GFP transcript is used as a primer binding site for reverse
transcription (RT) for first strand synthesis of the TES ribozyme intermediate. An
additional primer, specific for the 5’-end of the GFP-rPC ribozyme, is used for
polymerase chain reaction (PCR) in step 3 to amplify the TES ribozyme intermediate.
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Isolated RT-PCR products are subsequently ligated into a cloning vector (Step 4) and
sequenced for identification of TES ribozyme intermediates.
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ccgaguuaauagcccuggguauaguaacaauguugaauaugaaucuuuugcgagaugaaaugggugauc
cgcagccaaguccuaagggcauuuuugucuauggaugcaguucaacgacuagauggcaguggguauug
uaaggaauugcaguuuucuugcagugcuuaagguauagucuauccucuuucgaaagaaagaguauau
3’ Terminus of rPC-GFP

cuaG338-GUCCACacaaucugcccuuucgaaagaucccaacgaaaagagagaccacaugguccuuc
Start of 3’ end of GFP

uugaguuuguaacagcugcugggauuacacauggcauggaugaacuguacaacuga4533’
Downstream primer binding site
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Figure 3.11. Sequences of predicted RNA transcripts for isolation of in vivo TES
ribozyme intermediate. A. Sequence of the coding region of the GFP mRNA transcript
(720 nt). The nucleotides involved in P1 and P10 helix formation are denoted in bold,
black lettering. The region to be excised is denoted in bold, red lettering. The 5’ splice
site is denoted with an arrow. B. Sequence of the rPC-GFP ribozyme. The molecular
recognition elements RE1 and RE3 and the 3’ terminal guanosine (G338) are denoted in
bold, black lettering. Note that the rPC-GFP ribozyme is two nucleotides longer than the
normal rPC ribozyme due to RE3 consisting of five nucleotides. C. Sequence of the
predicted in vivo TES ribozyme intermediate. The TES ribozyme product will consist of
the 3’-end of the GFP transcript being covalently attached to the 3’-end of the rPC-GFP
ribozyme. The TES ribozyme intermediate is predicted to be 453 nt in length. The
upstream and downstream primer binding sites utilized for the RT-PCR strategy are
underlined.

56

CHAPTER FOUR-KINETIC CHARACTERIZATION OF THE FIRST STEP OF
THE RIBOZYME-CATALYZED TRANS EXCISION-SPLICING REACTION
INTRODUCTION
As previously discussed, a group I intron-derived ribozyme from Pneumocystis
carinii can catalyze the excision of a targeted sequence from within an RNA substrate
(8). The reaction, termed trans excision-splicing (TES), consists of two reaction steps;
substrate cleavage (intramolecular transesterification) followed by exon ligation (Figure
4.1). In the substrate cleavage reaction, the phosphodiester backbone of TES substrates
are cleaved through nucleophilic attack of a 3’ terminal guanosine (G336), generating
both 5’ and 3’ exon intermediates (see Chapter 3). In the exon-ligation step, a
nucleophilic uridine (at the 3’-end of the 5’ exon intermediate) performs a nucleophilic
attack upon a phosphodiester backbone position within the 3’ exon intermediate, resulting
in ligation of the exon sequences and excision of the internal segment (Figure 4.1). The
substrate cleavage reaction step is analogous to that in self-splicing (3), except that selfsplicing utilizes an intermolecular nucleophile (exogenous guanosine), while the TES
reaction utilizes an intramolecular nucleophile (endogenous guanosine). The TES
substrate cleavage reaction is similar to the cyclization reactions performed by group I
introns for generating both full-length and truncated circular introns (67-70, 101).
The establishment of kinetic frameworks has been useful for the dissection of the
individual steps of RNA catalyzed reactions (16, 72, 73, 102-111). The results obtained
from these types of studies have been mechanistically informative and have advanced our
fundamental understanding of the chemical basis for RNA catalysis. To further
investigate the fine details regarding the mechanism of the TES substrate cleavage
reaction, a minimal kinetic framework for the substrate cleavage reaction was established
(Figure 4.2).
There are several conclusions drawn from this kinetic framework as they relate to
the TES reaction. The rate constant for the substrate cleavage reaction is approximately
60-fold lower than that reported for the self-splicing reaction using a Tetrahymena
thermophila ribozyme, regardless of whether an intermolecular or intramolecular
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guanosine is being utilized as the substrate cleavage nucleophile (16, 17). The rate
constant for substrate dissociation is only 4-fold lower than that for substrate cleavage. In
addition, product dissociation is slower than the rate of cleavage which suggests that
multiple turnover, with respect to substrate cleavage, will likely be curtailed. The results
indicate that a conformational change exists between the two steps of the TES reaction.
Taken together, these results have greatly increased our current understanding of the
mechanism for the TES reaction. The kinetic framework presented herein will likely lead
to developing TES ribozymes that are more efficient at catalyzing the TES reaction either
in vitro or in vivo.
MATERIALS AND METHODS
Oligonucleotide Synthesis and Purification
RNA oligonucleotides were obtained from Dharmacon Research, Inc. (Lafayette,
CO) and were deprotected using the manufacturer’s standard protocol. Oligonucleotide
concentrations were calculated from UV absorption measurements using a Beckman DU
650 spectrophotometer (Beckman Coulter, Inc.; Fullerton, CA). Oligonucleotides were
5’-end radiolabeled via phosphorylation of the 5’ terminal hydroxyl group with [γ-32P]
ATP (Amersham Pharmacia Biotech; Piscataway, NJ) using T4 polynucleotide kinase
(New England Biolabs; Beverly, MA), as previously described (75).
Ribozyme Synthesis
The Pneumocystis carinii ribozyme plasmid, PC, was linearized in a 50 μL
reaction consisting of 16 μg of plasmid, 1 X REACT 2 buffer, and 50 units XbaI
(Invitrogen; Grand Island, NY) at 37 °C for 2 h. The linearized plasmid was isolated
using the QIAquick PCR purification kit (Qiagen; Valencia, CA). Run-off transcription
was performed for 2 h in a 50 μL reaction consisting of 1 μg of linear DNA, 50 units of
T7 RNA polymerase (New England Biolabs), 40 mM Tris-HCl (pH 7.5), 10 mM MgCl2,
5 mM DTT, 5 mM spermidine, and 1 mM rNTP mix. The individual ribozyme were
purified by a Qiagen Plasmid Midi Kit as previously described (8).
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Determination of Observed Substrate Cleavage Rate Constants (kobs and k2)
The first order rate constant for substrate cleavage, kobs, was measured under
single-turnover conditions, in which case the release of product would not affect the
observed rate constants. All reactions were conducted at 44 °C in H10Mg buffer, which
consists of 50 mM HEPES (25 mM Na+), 135 mM KCl, and 10 mM MgCl2 at pH 7.5.
These reaction conditions appear to be optimal for the TES reaction (8). For the pH
dependence studies, HEPES (pH 7.5) was replaced with MES (pH 5.0 - 6.8), HEPES (pH
6.8 - 7.5), or EPPS (pH 7.5 - 8.5). Reactions were initiated by adding 5 µL of an 8 nM
solution of 5’-end radiolabeled substrate [r(5’AUGACUdGCUC3’)] in the appropriate
buffer to a 25 µL solution of various concentrations of ribozyme (6 nM-360 nM) in the
same buffer. Note that the ribozyme solution was preincubated at 60 °C for 5 minutes and
then allowed to slow cool to 44 °C) to facilitate folding of the ribozyme prior to the
addition of the radiolabeled substrate. Aliquots (3 μL) were removed at specified times
and quenched with an equal volume of 2x stop buffer (10 mM urea, 0.1x TBE, 3 mM
EDTA). The substrate and products were denatured at 90 °C for 1 min and then separated
on a 12.5% denaturing polyacrylamide gel. The bands were visualized on a Molecular
Dynamics Storm 860 Phosphorimager and quantified using Imagequant software
(Molecular Dynamics). Data were fit using the Kaleidagraph curve-fitting program
(Synergy Software; Reading, PA). The final concentration of the radiolabeled substrate in
all reactions is 1.3 nM. A typical reaction utilized H10Mg buffer and a final ribozyme
concentration of 166 nM. Pseudo-first order rate constants for the appearance of products
were fit using the following single exponential equation:
[P]t = [P]∞(1-e-kt) [1]
In this equation [P]t and [P]∞ are the percentages of product formed at time t and at the
end point, respectively; and k is the first order rate constant.
Determination of the Substrate Dissociation Rate Constant (k-1)
Pulse-chase experiments (16, 112) were used to measure the rate constant for
substrate dissociation, k-1. In these experiments, 10 µL of 200 nM ribozyme in H10Mg
buffer was combined with 2 µL of 8 nM 5’ radiolabeled substrate in H10Mg buffer for a
period of t1 = 30 s. The ribozyme solution was preincubated at 60 °C for 5 min and then
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slow cooled to 44 °C before the addition of the substrate, which was also at 44 °C. The
chase phase was then initiated by taking out 5 µL of the reaction mixture and diluting the
reaction mixture with 25 µL of H10Mg buffer so that [E] < KM. During the chase period,
t2, dissociation of labeled substrate from the ribozyme is essentially irreversible. Aliquots
were removed at various times during the chase phase and the reaction was quenched by
adding an equal volume of 2X stop buffer. An otherwise identical reaction, but without
adding the chase (which in this case is buffer), was carried out in parallel. The first-order
observed rate constants kobs, chase and kobs, no-chase were obtained from a singleexponential fit of this data using Equation 1 (as a function of t2). The observed rate
constant for substrate dissociation (k-1) was then calculated (Equation 2) as the difference
between the two measured observed rate constants:
k-1 = kobs, chase - kobs, no-chase

[2]

Determination of the Substrate Association Rate Constant (k1)
The rate constant for substrate binding, k1, was measured using a series of pulsechase experiments. In each reaction, 5 µL of a ribozyme stock (from 36 to 240 nM) in
H10Mg buffer was combined with 1 µL 8 nM 5’-end labeled substrate and allowed to
react in a total volume of 6 µL. For each ribozyme concentration, several chase reactions
were initiated. In each chase, 1 µL of the original reaction mixture was removed and
diluted five-fold at various times, t1, ranging from 15 s to 120 s. The addition of chase
renders the dissociation of the substrate essentially irreversible. The chase reaction, t2,
was then allowed to proceed for 15 min, at which point the 5’ cleavage reaction was
essentially complete. The reaction was quenched with an equal volume of 2X stop buffer.
The percent product formed during the chase period was plotted against time t1. Observed
rate constants (kobs) were obtained by fitting the data to Equation 1. This observed rate
constant measures the rate of approach to equilibrium where substrate association is equal
to substrate dissociation. Hence, the rate of substrate association was obtained (16, 108)
by plotting kobs against ribozyme concentration and fitting to the equation:
kobs = k1 [E] + k-1
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Determination of the Dissociation Constant of the Ribozyme-Product Complex, ( KdP)
The equilibrium dissociation constant KdP of the 5’ exon mimic binding to the
ribozyme was determined using native polyacrylamide gel electrophoresis (75, 98, 103,
107). In this assay, several concentrations of ribozyme, ranging from 1.5 nM to 300 nM,
were preannealed in 5 μL total volume containing 3.4% glycerol and H10Mg buffer for 5
min at 60 °C. After the solutions slow cooled to 44 °C, 2.5 µL of a stock of 0.5 nM
radiolabeled 5’ exon mimic in H10Mg buffer at 44 °C was added. The mixture was
incubated at 44 °C for at least 90 min. To maintain the integrity of the bound species
during gel electrophoresis, the gel and the running buffer was made of H10Mg buffer and
they were prewarmed to 44 °C before the samples were loaded. The bound and unbound
5’ exon mimics were separated from each other by running 6 µL of each reaction on a
10% nondenaturing polyacrylamide gel. The gel was placed on chromatography paper
(Whatman 3MM CHR) and dried under vacuum for 30 min at 70 °C. The bands were
visualized on a Molecular Dynamics Storm 860 Phosphorimager. The bands were
quantified using ImageQuant software (Molecular Dynamics). Data were fit with
Kaleidagraph curve-fitting program (Synergy Software) using the equation:
θ = [ribozyme]u /([ribozyme]u + Kd)
In this equation, Kd is the equilibrium dissociation constant of the 5’ exon mimic,
θ is the fraction of 5’ exon mimic bound to the ribozyme, and [ribozyme]u is the
concentration of unbound ribozyme in the reaction (75, 113).
Determination of Rate Constant of Sustrate Cleavage Product Dissociation (k-3)
The dissociation rate constant of the 5’ exon intermediate (k-3), was measured by a
pulse-chase protocol, followed by analysis of the ribozyme/product complex using native
polyacrylamide gel electrophoresis. In a typical experiment to measure k-3, A solution of
300 nM ribozyme in 10 μL H10Mg buffer containing 3.4% glycerol was preincubated for
5 min at 60 °C and then allowed to slow cool to 44 °C. Then 5 µL of 0.5 nM 5’-end
labeled 5’ exon intermediate was added and the reaction mixture was incubated at 44 °C
for 30 min to allow complete binding. A chase reaction was then initiated by the addition
of 40 µL of 5.4 μM unlabeled 5’ exon intermediate (in reaction buffer) to follow the
dissociation of 5’ exon intermediate from the ribozyme-5’ exon complex. The final

61

concentrations of the reactants in the chase reaction were 40 nM ribozyme, 33 pmol 5’end labeled substrate cleavage product, and 4 μM unlabeled 5’ exon intermediate (as
chase) in 50 µL reaction volume. Time points were taken by removing 5 μL aliquot from
the reaction mixture and immediately loaded onto a running 10% native polyacrylamide
gel. The dissociation rate was obtained using equation 1. Additionally, the rate constant
of substrate cleavage product association (k3) was obtained (111) using the equation:
k3 = k-3/KdP.
RESULTS
A kinetic scheme for the substrate cleavage reaction is summarized in Figure 4.2.
One complication in studying the substrate cleavage reaction step, however, is that the
second reaction step of TES (exon ligation) proceeds immediately after the first step (19).
Therefore, a previously described modified substrate system [r(5’AUGACUdGCUC3’)]
that contains a deoxyguanosine at the site of excision has been shown to prevent the
second reaction step of TES (see Chapter 3, Figure 3.4). To test the ability of this new
deoxyguanosine substrate to undergo the substrate cleavage reaction, it was allowed to
react with the ribozyme under optimized TES reaction conditions (8). We found that the
deoxyguanosine substrate (kobs value of 3 ± 0.5 min-1) only minimally reduces the
observed rate constant of the substrate cleavage reaction as compared to the normal
substrate (kobs value of 3.7 ± 0.2 min-1). Therefore, the deoxyguanosine substrate
reasonably mimics the normal substrate as a first reaction step substrate. Importantly, this
substrate inhibits the exon-ligation step, allowing us to isolate and analyze only the first
reaction step.
Observed Rate Constants for Substrate Cleavage, kobs and k2
Ribozyme excess conditions were used to determine the pseudo-first-order rate
constant for the substrate cleavage reaction. Note that under these reaction conditions the
ribozyme-product complex is denatured upon addition of stop buffer, and so product
dissociation is not observable. Therefore, these experiments measure the rate of substrate
cleavage from the ribozyme-substrate complex.
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The observed rate constants (kobs) were measured in reactions containing various
ribozyme concentrations (5-300 nM) and 1.3 nM of 5’-end radiolabeled substrate
(Figures 4.3A and 4.3B). As seen in Figure 4.3C, the observed rate constants at the higher
ribozyme concentrations (100-350 nM) are independent of ribozyme concentration. This
indicates that saturation of the ribozyme has been reached. A value of k2 = 4.1 ± 0.5 min-1
and KM = 102 ± 0.4 nM were obtained by fitting the average kobs values to the MichaelisMenten equation. Herein, k2 represents the maximum first order rate of substrate cleavage
under single turnover conditions. For lower ribozyme concentrations, 5-40 nM, the kobs
values for the substrate cleavage reaction increase linearly with ribozyme concentration.
This linear dependence reflects the apparent second order rate constant, k2/KM, and the
slope gives a value of (2.8 ± 0.5) x 107 M-1 min-1 (Figure 4.3D). Note the values obtained
are similar to values previously reported for other group I intron-derived ribozymes (72,
73, 114).
Dependence of Substrate Cleavage on pH
It has been reported that the rate of substrate cleavage step in Tetrahymena (16),
Anabaena (72), and Azoarcus (73) group I introns, as well as reaction steps for some
small ribozymes (115-117), show a log-linear increase in the reaction rate constant with
increasing pH in the acid range (up to pH 7). This is consistent with a single
deprotonation step that activates the cleavage nucleophile, prior to the substrate cleavage
reaction (118). This is also consistent with the observed rate constant at a given pH being
equivalent to the rate constant of the chemical step at that pH. This was investigated for
the Pneumocystis ribozyme by measuring the pH dependence of the observed rate
constant of the substrate cleavage reaction. As seen in Figure 4.4, the logarithm of the
observed rate constant increases linearly with pH in the range of 5 to 7 (slope = 0.5 ±
0.03), but not at higher pH values. In the case of the Tetrahymena group I intron-derived
ribozyme, such non-linear behavior was attributed to a pH-dependent conformational
change occurring within the ribozyme (119, 120). This conformational change thus sets a
limit on the observed rate constant of cleavage (k2), even though the rate constant of
chemistry (kc) is expected to continue to increase with increasing pH (119, 120).
Apparently, for our substrate cleavage reaction, the rate of the chemical step is potentially
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being masked by a similar conformational change, and so k2 is not equivalent to kc. The
rate of chemistry (kc), however, can be approximated by extrapolating the log-linear
increase that occurs between pH of 5 and 7 to higher pH values. In our case, kc is then
approximately equal to 5.7 ± 1.1 min-1 at pH 7.5 (Figure 4.4).
Control experiments were run to determine whether the observed rate constants
shown in Figure 4.4 were being influenced by the specific buffers utilized in the
respective reactions. We found that the values obtained using MES and HEPES at pH 6.8
were within standard deviation of each other. This was also true using HEPES and EPPS
at pH 7.5. Apparently, there is not a buffer-specific effect on the observed rate constants
(kobs). Note that we have not examined the rates of substrate cleavage outside the pH
range depicted because protonation or deprotonation of nucleotides is expected to cause
general chemical denaturation of the ribozyme (121).
Rate Constant for Substrate Dissociation, k-1
The upper limit of the rate constant for substrate dissociation was measured in a
pulse-chase experiment. In this experiment, the time chosen for t1 (30 s) was such that a
significant fraction of the substrate would remain unreacted. After the addition of the
chase, which in this case is dilution with buffer, aliquots were removed at designated
times up to 15 min. An otherwise identical reaction, but without the added chase, was
carried out in parallel. The observed rate constants for the chase reaction (kobs, chase = 2.5
± 0.04 min-1) and in the reaction without added chase (kobs,

no-chase

= 1.5 ± 0.01 min-1)

were obtained from a single-exponential fit of product formation against t2 (Figure 4.5).
The substrate dissociation rate constant (k-1 = 0.9 ± 0.04 min-1) was then determined
using Equation 2 (see Materials and Methods). Note that k-1 is comparable in value to the
cleavage step (k2), implying that the ribozyme-substrate complex does not reach
equilibrium with free ribozyme prior to the cleavage step.
Rate Constant for Substrate Association, k1
The kinetic data indicates that substrate dissociation is comparable in value to the
cleavage step. This implies that the second-order rate constant, k2/KM, will be a
combination of substrate association (k1), dissociation (k-1) and cleavage (k2) steps. Thus,
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the second-order rate constant can be represented as k2/KM = k1k2/(k-1 + k2) (122). As
discussed earlier, a value of 2.8 x 107 M-1 min-1 was obtained for the second order rate
constant k2/KM. Using this value of k2/KM and the values of k2 and k-1 (4.1 min-1 and 0.9
min-1 respectively), the calculated value of k1 is 3.4 x 107 M-1 min-1.
For confirmation, k1 was directly measured in a pulse-chase experiment. In this
case, ribozyme and radiolabeled substrate were combined for varying times, tl (15 s to
120 s), and then chased with excess buffer to prevent further binding. The mixtures were
then incubated for a time t2 = 15 min, which ensures that essentially every substrate
molecule that binds to the ribozyme during tl is converted to product. The amount of
product formed was plotted against time t1 (Figure 4.6). The kobs values reflect the rate of
approach to equilibrium of the ribozyme-substrate complex formation, which is
represented by kobs = k1 [E] + k-1. The slope of the plot of kobs versus ribozyme
concentration gives the rate of substrate association, kl = (1 ± 0.01) x 107 M-1 min-l
(Figure 4.6), which is in reasonable agreement (for ribozyme reactions) with the
calculated value above.
Reversibility of the Substrate Cleavage Reaction
Under single turnover conditions, the first order rate constant (k2) of the substrate
cleavage reaction is 4.1 min-1 (Figure 4.3), with a typical end point of 70-80%. Over the
time period of 15 to 60 min, this end point does not change, indicating that either an
internal equilibrium exists between ribozyme-substrate and ribozyme-product complexes
or only 70-80% of the substrate is reactive. Such an internal equilibrium has previously
been identified in a guanosine-dependent substrate cleavage reaction catalyzed by a
Tetrahymena group I intron-derived ribozyme (17). Therefore, a pulse-chase experiment
was conducted such that this equilibrium, if occurring, could be disturbed and thus
detected (17). In this assay, the substrate cleavage reaction was allowed to proceed to
completion and then an excess of unlabeled 5’ exon mimic was added. The addition of a
large excess of unlabeled 5’ exon mimic is expected to prevent rebinding of any
dissociated radiolabeled substrate or radiolabeled 5’ exon reaction product. The result
(Figure 4.7) shows that a substantial fraction of the bound radiolabeled product can be
converted back to radiolabeled substrate, hence an internal equilibrium exists.
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Furthermore, the results imply that product dissociation is slower than or similar to
substrate dissociation (17).
Equilibrium Dissociation Constant of the Substrate Cleavage Product, KdP, and
Substrate, KdS
A trace amount of 5’-end labeled substrate cleavage product (the 6-mer) was
incubated with various concentrations of ribozyme for 90 min at 44 °C in H10Mg buffer,
and the ribozyme-product complex was then partitioned from the unbound product on a
native polyacrylamide gel (75, 113). The equilibrium dissociation constant of the 5’ exon
product (KdP = 69 ± 6 nM) was then determined from a plot (Figure 4.8) of the fraction
product bound versus ribozyme concentration (75, 113).
The equilibrium dissociation constant of the substrate, KdS, is not directly
measurable because the substrate cleavage reaction occurs before the binding equilibrium
is established. An estimated value of the equilibrium dissociation constant of the
substrate can be obtained, however, from the equation KdS = (k-1 /k1) = 90 nM.
Rate Constant for Dissociation of the 5’ Exon Product, k-3
The product dissociation rate constant (k-3) was determined using a pulse-chase
assay, combined with native polyacrylamide gel electrophoresis. In this assay, an excess
of ribozyme was mixed with 1.3 nM 5’-end labeled 5’ exon mimic, which was then
incubated in H10Mg buffer containing 3.4 % glycerol at 44 °C for 30 min. An excess
amount of unlabeled 5’ product was then added to initiate the chase, and aliquots were
removed at designated times. These aliquots were directly loaded onto a running native
polyacrylamide gel to isolate the bound and unbound fractions. For quantification, the
amount of product not bound after the chase was subtracted from that at time t1, which
yields the amount of product dissociated due to the chase. The rate of product
dissociation (k-3 = 0.09 ± 0.05 min-1) was then obtained from fitting Equation 1 to a single
exponential function (Figure 4.9). Apparently, product dissociation is slower than
substrate dissociation, which show that the substrate cleavage reaction is not an effective
multiple turnover reaction.
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DISCUSSION
The Pneumocystis carinii ribozyme catalyzes the excision of internal segment
from within an RNA substrate (see Figure 4.1). The first reaction step (substrate
cleavage) is catalyzed by the 3’ terminal guanosine (G336) of the Pneumocystis ribozyme
(see Chapter 3) and is similar to the cyclization reactions catalyzed by group I introns for
the creation of both full-length (FLC) and truncated circular group I introns (67-70, 101).
To further enhance our current understanding of the mechanism of the substrate cleavage
reaction; a minimal kinetic scheme was developed for the individual steps of the substrate
cleavage reaction. The use of a deoxyribose-containing substrate allowed the isolation of
the first reaction step (substrate cleavage) while disallowing the second reaction step
(exon ligation). Note, however, that in the context of the full TES reaction, the substrate
cleavage product is actually an intermediate, between the two reaction steps.
Substrate Binding
The rate constant for the substrate binding the Pneumocystis ribozyme, k1, is far
below the diffusional limit of 1011 M-1 min-1 for the collision of small molecules (123).
Thus, unlike classical enzymes which react near diffusion-controlled limits (122, 124126), the Pneumocystis ribozyme is not under diffusion control. This value, however, is
within the range (107 - 109 M-1 min-1) expected for the formation of RNA duplexes (127131), as seen with other ribozymes (16, 103, 108, 110, 111, 132). Thus, the rate of
assembly of the Pneumocystis ribozyme-substrate complex appears to be limited by the
process of helix formation. Nevertheless, because k2/KM (k2 = 4.1 min-1 and KM = 102 nM
respectively) approaches the rate of substrate association, catalysis can be expected to
occur about as fast as base pairing between the ribozyme and substrate. This is typical of
ribozymes that bind their substrates through double helices (16, 108, 109, 111, 133). Of
equal importance is that the on-rate of the substrate, k1, is 7 orders of magnitude faster
than the off rate, k-1. Therefore, the substrate is relatively slow to dissociate from the
ribozyme once bound.
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Substrate Cleavage
The rate constant for the substrate cleavage reaction, k2, under single turnover
conditions was determined to be 4.1 min-1. Though it appears that the true rate constant
for the actual chemical step is being masked, probably by a local conformational change
that occurs after substrate binding and before the actual chemical step, this rate is
approximately four times faster than the rate constant for substrate dissociation (k-1 = 0.9
min-1). Although the substrate is more likely to react than it is to dissociate, the similar
order of magnitude suggests that a non-trivial fraction of the substrate will dissociate
before the substrate cleavage reaction occurs.
The ‘catalytic power’ of an RNA-cleaving ribozyme can be estimated by
comparing the observed rate constant of a catalyzed reaction to that of an equivalent
uncatalyzed reaction. Under simulated physiological conditions, the uncatalyzed rate
constant of the phosphotransesterification reaction (knoncat) is estimated to be 10-9 min-1
(16, 134). Thus, a rate of 4.1 min-1 for the substrate cleavage reaction represents a
catalytic rate enhancement (k2/knoncat) of approximately 109-fold. This rate enhancement
also corresponds to approximately 13 kcal/mol of transition-state stabilization according
to the following equation: ∆G° = -RT ln (k2/knoncat), as discussed (16).
It was previously reported that a Tetrahymena ribozyme can also catalyze a 3’
terminal guanosine-mediated substrate cleavage reaction (13, 15, 17, 68), albeit under
different optimized conditions using different substrates. In one such study (17), the 3’
terminal guanosine catalyzed reaction was reported to behave similar to the exogenous
guanosine catalyzed reaction, for which kc = 350 min-1 (16). In comparison, the
Pneumocystis endogenous reaction is approximately 60-fold slower (kc = 5.7 min-1). This
substantial difference might be due to the Tetrahymena ribozyme being faster than the
Pneumocystis ribozyme, the difference in reaction conditions, or that the endogenous
guanosine nucleophile in the Pneumocystis ribozyme, although bound to the GBS, is not
bound in an ideal orientation. Indeed, this last idea could be supported in that proper
alignment of the endogenous guanosine nucleophile with respect to the Pneumocystis
ribozyme could be hindered by the absence of a P9.0 helix interaction, which is predicted
to align the intramolecular guanosine into the GBS (17). Although more detailed studies
using the same reaction conditions and sequences would have to be conducted in order to
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make these comparisons more concrete, it is apparent that the intramolecular guanosinemediated substrate cleavage reaction is substantially slower than either intermolecular or
intramolecular guanosine-mediated substrate cleavage reaction for the case of the
Tetrahymena ribozyme.
Furthermore, the observed rate constant of substrate cleavage shows pH
independence between pH 7 and 8.5 implying that at this range the rate of chemistry
associated with substrate cleavage is masked by a conformational change (119, 120). The
simplest interpretation of this result is that the rate of substrate cleavage is not equivalent
to the rate of chemistry, and that the rate of chemistry (extrapolated to be kc = 5.7 min-1)
is faster than the rate of substrate cleavage (measured to be k2 = 4.1 min-1).
Product Dissociation
For the fraction of substrates that do undergo the reaction, the resultant products
dissociate from the ribozyme relatively slowly on the time scale of the reaction.
Furthermore, dissociation of the 5’ exon product is slower than the cleavage step (by
about 45-fold), which significantly impedes the ribozyme from catalyzing multiple
turnover reactions. Of course, the 5’ exon product of the cleavage reaction is an
intermediate in the complete TES reaction, and so slow product dissociation is beneficial
for the TES reaction as a whole. In addition, the product off-rate, k-3, is 20-fold slower
than the substrate off-rate, k-1. Apparently, there are additional or more stable interactions
that the ribozyme uses to bind the product relative to the ribozyme binding the substrate.
This is perhaps due to destabilization of substrate binding via positioning of the 3’
bridging phosphoryl oxygen at the cleavage site next to a required Mg ion in the ground
state (135). As negative charge develops on the 3’ oxygen upon entering the transition
state, this interaction will become more favorable. This transition state stabilization is
thought to be an important stabilization/destabilization factor in ribozyme-substrate
binding (135).
A Conformation Change Exists Between the Two Steps of the TES Reaction
The substrate guanosine to be excised (G1) and its 2’-OH group are required for
the second step of TES (18), similar to (if not the same as) the role of the ωG in the
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second step of self-splicing (57, 63, 136-141). This suggests that the G1 is likely binding
to the GBS of the ribozyme prior to the exon-ligation step of TES. In the substrate
cleavage step, however, the 3’ terminal guanosine (G336) of the ribozyme (Figure 4.1) is
binding to that same GBS. Therefore, for the TES reaction, there is likely a local
conformational change between the two reaction steps that sees the G1 displace the
ribozymes 3’ terminal guanosine for binding into the GBS (Figure 4.1). That there exists
a conformational change is further supported by kinetic data that shows that for the
substrate cleavage reaction, substrate dissociation is faster than product dissociation
(Figure 4.2), implying that different (strengths of) interactions hold the substrate and the
5’ exon cleavage product. The local conformational change that occurs in TES is likely
similar to the local conformational change that occurs in self-splicing, with the
displacement of the exogenous guanosine by the ωG of the intron (3, 46, 47, 59).
Nevertheless, as TES uses an intramolecular nucleophile and self-splicing uses an
intermolecular nucleophile, the local conformational changes between the two steps of
each reaction are likely not identical.
Implications for TES applications
TES substrates, once bound, are four times more likely to undergo the substrate
cleavage reaction as they are to dissociate. Therefore, to make more effective TES
ribozymes, one could decrease the rate of substrate dissociation relative to that for the
substrate cleavage reaction. Potential strategies for achieving this are to increase the
strength of helix P1, either through target selection or elongation of helix P1. Note,
however, that this strategy could result in a decrease in the rate of substrate cleavage.
The results also suggest that the Pneumocystis ribozyme catalyzes the substrate
cleavage reaction (catalyzed by either an exogenous or endogenous guanosine)
approximately 60-fold slower than the Tetrahymena ribozyme. These results suggest that
the rate of the substrate cleavage reaction could be improved upon by decreasing the rate
of substrate dissociation before the cleavage step.

Copyright © Perry Patrick Dotson II 2008
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Figure 4.1. Schematic of the two-step TES reaction. The rPC ribozyme is in uppercase
lettering and, the 10-mer substrate is in lowercase lettering, and the ribozyme recognition
elements RE1 and RE3 base pair with the substrate to form helices P1 and P10,
respectively. The sites of catalysis for the first step (substrate cleavage) and the second
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step (exon ligation) are shown with arrows, and the guanosine to be excised (G1) is
circled. The diagram shows only the recognition elements of the ribozyme.
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kc = 5.7 min-1

KdS = 90 nM
E

k1 = 1x107 M-1 min-1
k-1 = 0.9

E●*S

k2 = 4.1 min-1

min-1

KdP = 69 nM
E●P

k-3 = 0.09 min-1

E+P

k3 = 3.5 x 107 M-1min-1

Figure 4.2. Kinetic scheme for the substrate cleavage reaction. E denotes the rPC
ribozyme, S denotes the 10-mer substrate, and P denotes the 6-mer cleavage product. All
rate and equilibrium constant values were measured or calculated (boxed values) in this
report. The scheme includes rate constants for substrate association (k1) and dissociation
(k-1), cleavage (k2), and product association (k3) and dissociation (k-3). Note that the
observed rate constant for the cleavage step (k2) is distinguishable from the actual rate
constant for chemistry (kc). The scheme also includes equilibrium constants for substrate
(KdS) and product (KdP) dissociation.
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Figure 4.3. Substrate cleavage reactions. All reactions were conducted in H10Mg buffer.
(A) Representative polyacrylamide gel with the 5’-end labeled substrate and 166 nM rPC
ribozyme. The positions of the substrate and the substrate cleavage product on the gel are
labeled. The lane marked (+) buffer contains a 15 min reaction in the absence of the
ribozyme. (B) Representative plot of the substrate cleavage reaction at 5 nM (▲), 10 nM
(○), 20 nM (□), 40 nM (◊), 166 nM (∆), and 300 nM (●) ribozyme concentration. All data
points between the two independent assays have a standard deviation less than 15%. (C)
Fit of the average kobs values from panel B versus ribozyme concentration (0-350 nM) to
the Michaelis-Menten equation. The plot resulted in a value of k2 = 4.1 ± 0.5 min-1 and
KM = 102 ± 0.4 nM respectively. These values are the average of the two independent
assays. D. Linear fit of the average kobs values from panel B versus ribozyme
concentration (5-40 nM). The resulting k2/KM value (2.8 ± 0.5 x 107 M-1 min-1) is the
average of the two independent assays.
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Figure 4.4. pH dependence of the observed rate of substrate cleavage. Values for were
obtained from single turnover reactions at 44 °C using 166 nM ribozyme, 1.3 nM 5’-end
labeled substrate in buffer containing 135 mM KCl and 10 mM MgCl2. The buffers used
for this study were 50 mM MES (pH 5.0-6.8), 50 mM HEPES (pH 7.0, 7.5), or 50 mM
EPPS (pH 8.0, 8.5). Each rate is the average of two independent measurements and has a
standard deviation less than 15%. The solid line represents the log-linear increase in the
data set from pH of 5 to 7 (slope = 0.5 ± 0.03). The extrapolation of the line to pH 7.5
(depicted by dashed lines) gives a value of 0.75 ± 0.1 which corresponds to rate of
chemistry (kc) of 5.7 ± 1.1 min-1.
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Figure 4.5. Determination of the rate constant for substrate dissociation, k-1. (A) Scheme
of the pulse-chase experiment, which was conducted in H10Mg buffer at 44 °C and 166
nM ribozyme. The chase was initiated by diluting the reaction mixture with H10Mg
buffer. (B) Representative plot of cleaved substrate, after t1, versus time (t2) with chase
(closed circles) and without added chase (open circles). The resultant first order rate
constants obtained with the chase (kobs, chase = 2.5 ± 0.04) and without the chase (kobs, nochase

= 1.5 ± 0.01 min-1) are the average of two independent assays. All data points

between the two independent assays have a standard deviation less than 10%. From this
data, the rate of substrate dissociation, k-1, is 0.9 ± 0.04 min-1.
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Figure 4.6. Determination of the rate constant for substrate association, k1. (A)
Representative plot of pulse-chase experiments in H10Mg buffer at 44 °C with five
different ribozyme concentrations: 30 nM (○), 50 nM (▲), 100 nM (◊), 150 nM (♦), and
200 nM (●). All data points between the two independent assays have a standard
deviation less than 10%. (B) Representative plot of the kobs values against ribozyme
concentration. The line is fit to the equation kobs = k1[E] + k-1 and the substrate association
rate (k1 = 1 ± 0.01 x 107 M-1 min-l) was calculated from the slope. Note that the error bars
present on the graph are too small to be seen.
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Figure 4.7. Substrate cleavage products undergo the reverse reaction. A plot of the
disappearance of substrate in a normal reaction (no chase, closed circles) and
reappearance of the substrate in the presence of chase (open circles). Each point on the
plot is the average of two independent experiments, and has a standard deviation less than
10%. Note that the error bars present on the graph are too small to be seen.
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Figure 4.8. Determination of the equilibrium dissociation constant of the substrate
cleavage product, KdP. In the reaction, various concentrations of ribozyme were mixed
with trace amounts of 5’-end radiolabeled substrate cleavage product in H10Mg buffer
containing 3.4 % glycerol. Shown is a representative plot of the percent substrate
cleavage product bound to the ribozyme versus ribozyme concentration. The resultant
value of KdP is 69 ± 6 nM is the average of two independent assays with each data point
having a standard deviation less than 15%.
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Figure 4.9. Determination of the rate constant for dissociation of the 5’ exon product, k-3.
Representative plot of the fraction of unbound product versus chase time, t2. The rate of
product dissociation, k-3, is 0.09 ± 0.05 min-1, which is the average of two independent
assays with each data point having a standard deviation typically less than 20%.
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CHAPTER FIVE- THE TRANS EXCISION-SPLICING REACTION CAN BE
CATALYZED BY GROUP I INTRON-DERIVED RIBOZYMES FROM
TETRAHYMENA THERMOPHILA AND CANDIDA ALBICANS
INTRODUCTION
Group I intron-derived ribozymes, which are essentially exon-less introns, have
previously been shown to catalyze non-native reactions that are similar to the selfsplicing reaction (3, 6). In one such reaction, termed trans excision-splicing (TES), an
intron-derived ribozyme from Pneumocystis carinii catalyzes the excision of an internal
segment from within an RNA substrate, resulting in the reattachment of the flanking
regions (Figure 5.1) (8). The TES reaction, which is similar to other ribozyme-mediated
reactions, proceeds through two consecutive transesterification reactions: substrate
cleavage followed by exon ligation (Figure 1). For the substrate cleavage reaction, the 3’
terminal guanosine of the Pneumocystis ribozyme catalyzes the intramolecular cleavage
of TES substrates (Figure 5.1) (see Chapter 3). Substrate cleavage is followed by exon
ligation, resulting in formation of the final TES products (Figure 5.1).
In general, group I intron-derived ribozymes contain all the structural elements
required for catalyzing the TES reaction. This suggests that group I intron-derived
ribozymes other than P. carinii could catalyze the TES reaction. Therefore, intronderived ribozymes from Tetrahymena thermophila and Candida albicans were
constructed and tested for their ability to catalyze TES reactions, using as substrates their
own native 5’ and 3’ exon sequences (Figure 5.2) (71, 74).
In this study, the Tetrahymena and Candida ribozymes were shown to catalyze
the excision of a single nucleotide from within their ribozyme-specific substrates.
Furthermore, both ribozymes were shown to catalyze substrate cleavage through
intramolecular transesterification, similar to the Pneumocystis ribozyme. The overall
yield of TES reactions, however, differed between the individual ribozyme constructs.
The Tetrahymena and Candida ribozyme constructs were shown to catalyze the
individual steps of TES less efficiently (~20% lower yields) than the Pneumocystis
ribozyme. This variation appears to be due to the individual ribozymes ability to
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productively utilize their 3’ terminal guanosine as the intramolecular nucleophile.
Overall, however, the results demonstrate TES is a general ribozyme-mediated reaction.
MATERIALS AND METHODS
Oligonucleotide Synthesis and Preparation
DNA oligonucleotides were obtained from Integrated DNA Technologies
(Coralville, IA) and were used without further purification. RNA oligonucleotides were
obtained from Dharmacon Research, Inc. (Lafayette, CO) and were deprotected using the
manufacturer’s suggested protocol. Concentrations of individual oligonucleotides were
calculated

from

UV

absorption

measurements

using

a

Beckman

DU

650

spectrophotometer (Beckman Coulter, Inc.; Fullerton, CA). RNA oligonucleotides were
5’-end radiolabeled by phosphorylation of the 5’ terminal hydroxyl group with [γ-32P]
ATP (Amersham Pharmacia Biotech; Piscataway, NJ) using T4 polynucleotide kinase
(New England Biolabs; Beverly, MA) as previously described (75). RNA
oligonucleotides were 3’-end radiolabeled by ligation of radiolabeled pCp (5’-*pCp) to
the 3’-end of the RNA oligonucleotide using T4 RNA ligase (New England Biolabs), as
previously described (10). Note that 3’-end radiolabeling results in substrates being one
nucleotide longer than 5’-end radiolabeled substrates.
Plasmid Construction
For these studies, two ribozyme constructs were created: pT-X, derived from the
plasmid pT7L-21 (kindly provided by Douglas H. Turner, University of Rochester;
Rochester, NY) which contains the Tetrahymena ribozyme (71), and pC, derived from
the plasmid pC10/1x (provided by Douglas H. Turner) that contains the Candida
ribozyme (74). The individual ribozyme sequences were modified to include an RE3
sequence so that a P10 helix interaction would form upon binding substrate (see Figure
5.2).
The plasmids, pT and pC, were made by changing the parental plasmids, pT7L-21
and pC10/1x, via site directed mutagenesis. The pT plasmid was created using a single
round of site directed mutagenesis using the primer pairs (underlined bases represent
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inserted

nucleotides)

5’

CGACTCACTATAGACCTTTGGAGGGAAAAG3’

and

5’

CTTTTCCCTCCAAAGGTCTATAGTGAGTCG3’ for RE3 formation. The pC plasmid

was created using a single round of site-directed mutagenesis using the primer pairs
5’

CGACTCACTATAGGTAAGGGAGGCAAAAGTAGGG3’

and

5’

CCCTACTTTTGCCTCCCTTACCTATAGTGAGTCG3’ for RE3 formation. Note that

a guanosine was inserted at the 5’-end of the each ribozyme construct to ensure efficient
transcription by T7 RNA polymerase (92).
Additionally, an XbaI restriction site was inserted at the 3’-end of the pT plasmid,
which creates a terminal guanosine (required for the intramolecular transesterification
reaction), as well as making the 3’-ends of all the ribozymes the same (see Chapter 3).
The plasmid, pT-X, was created in two rounds using the following primer pairs
(underlined

bases

represent

changes

to

the

3’-end

of

the

ribozyme)

5’

GGAGTACTCGATAAGGTAGCCAAATGCC3’

and

5’

GGCATTTGGCTACCTTATCGAGTACTCC3’ for the first round. The primer pairs

5’

GGAGTACTCTAGATAAGGTAGCCAAATGCC3’

and

5’

GGCATTTGGCTACCTTATCTAGAGTACTCC3’ were used for the second round.
Each set of primers (22.5 pmol for each primer) was used in an amplification

reaction consisting of 25 ng parental plasmid (pT7L-21, pT, or pC10/1x), 2.5 units Pfu
DNA polymerase (Stratagene; La Jolla, CA), and 0.5 mM dNTPs (Invitrogen; Grand
Island, NY) in a buffer consisting of 10 mM KCl, 10 mM (NH4)2SO4, 20 mM Tris-HCl
(pH 8.8), 2 mM MgSO4, 0.1% Triton X-100, and 0.1 mg/mL BSA (total reaction volume
is 50 μL). After an initial denaturation for 30 s at 95 °C, the mixture was subjected to 20
cycles of 95 °C for 30 s, 50 °C for 2 min, and 68 °C for 6 min. Parental plasmid was then
digested with 20 units DpnI (New England Biolabs) in 4.1 μL of the manufacturer’s
supplied buffer (10X NEBuffer 4) for 2 h at 37 °C. A 3 μL aliquot of this mixture was
then used to transform Escherichia coli DH5α competent cells (Gibco BRL). The vectors
were purified using a QIAprep Spin Miniprep Kit (QIAGEN; Valencia, CA), and were
sequenced for confirmation of the individual changes (Davis Sequencing; Davis,
California).
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Ribozyme Synthesis and Purification
The Pneumocystis plasmid (PC) (8), the Tetrahymena plasmid (pT-X), and the
Candida plasmid (pC) were linearized in a 50 μL reaction consisting of 16 μg plasmid, 5
µL 10X REACT 2, and 50 U of XbaI (Invitrogen; Grand Island, NY). The reactions were
incubated at 37 °C for 2 h followed by purification using a QIAquick PCR purification
kit (Qiagen) using the manufacturers suggested protocol. The resulting linearized
plasmids were subjected to run-off transcription reactions in a 50 μL volume consisting
of 1 μg DNA template, 50 U of T7 RNA polymerase (New England Biolabs), 40 mM
Tris-HCl (pH 7.5), 10 mM MgCl2, 5 mM DTT, 5 mM spermidine, and 1 mM rNTP mix.
The reactions were incubated at 37 °C for 2 h, at which time each ribozyme construct was
purified using a Qiagen Plasmid Midi Kit (Qiagen), as previously described (8).
Concentrations of individual ribozymes were calculated from UV absorption
measurements using a Beckman DU 650 spectrophotometer (Beckman Coulter, Inc.)
using the previously reported extinction coefficient of 3.5 x 106 M-1 cm-1 for the
Pneumocystis (rPC) ribozyme (75), 3.2 x 106 M-1 cm-1 for the Tetrahymena (rT-X)
ribozyme (71), and 3.72 x 106 M-1 cm-1 for the Candida (rC) ribozyme (74).
TES Reactions
Reactions were performed at 44 °C in buffer consisting of 50 mM Hepes (25 mM
Na+), 135 mM KCl, and various concentrations of MgCl2. TES reactions were optimized
for magnesium concentration (0-35 mM MgCl2), ribozyme concentration (0-500 nM),
and time (1-45 min). In each case, TES reaction conditions were optimized to give the
greatest TES product yield. Briefly, a ribozyme solution, in HXMg buffer, lacking
substrate was preannealed at 60 °C for 5 min, and then slow cooled to 44 °C. Reactions
were initiated by the addition of 1 μL of 8 nM 5’-end radiolabeled substrate (10-mer,
5’

AUGACUGCUC3’ for rPC; 13-mer,

5’

CUCUCUGAAAGGU3’ for rT-X; or 11-mer,

5’

GACUCUGCUUA3’ for rC). Note that the italic lettering in the substrates represent the

nucleotide to be excised. The final concentration of the substrates in the reaction mixtures
was 1.3 nM. For mechanistic studies, 3’-end radiolabeled substrates were employed at the
same concentrations stated above. Reactions were conducted at 44 °C for the optimized
amount of time, and stopped by adding an equal volume of stop buffer (10 M urea, 3 mM
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EDTA, and 0.1X TBE). Reactions were denatured for 1 min at 90 °C and substrates,
intermediates, and products were separated on a 12% polyacrylamide/8 M urea gel. The
gel was transferred to chromatography paper (Whatman 3MM CHR) and dried under
vacuum. The bands were visualized and quantified on a Molecular Dynamics Storm 860
Phosphorimager.

Kinetic Studies
The observed rate constant (kobs) for the individual steps of the TES reaction,
using each ribozyme construct, was obtained under single-turnover ‘ribozyme excess’
conditions.

In these experiments, 35 μL of ribozyme in appropriate buffer was

preannealed at 60 °C for 5 min and slow cooled to 44 °C. The reactions were initiated by
the addition of 7 μL of 8 nM 5’-end radiolabeled substrate (10-mer, 5’AUGACUGCUC3’
for rPC; 5’CUCUCUGAAAGGU3’ for rT-X; or 5’GACUCUGCUUA3’ for rC), bringing
the final concentration to 1.3 nM substrate. A 3 μL aliquot was periodically removed and
added to an equal volume of stop buffer. The reactants and products were separated on a
12% polyacrylamide/8 M urea gel, and the gel was dried under vacuum. The resulting
bands were visualized and quantified as described above. The observed rate constants for
the substrate cleavage step (substrate cleavage plus TES product over time) and for exon
ligation (TES product over time) were quantified as previously described (8).

RESULTS
To simplify the comparison of the individual ribozyme constructs, our simplest
TES model test system was utilized. Successful TES reactions will result in the excision
of a single nucleotide from within their ribozyme-specific substrates. For these studies,
the previously constructed Tetrahymena and Candida ribozymes were modified in two
ways (see Figure 5.2). First, the initial ribozyme constructs lacked the nucleotides
required to form the P10 helix (RE3), and so an RE3 region (native to the ribozyme) was
added. As seen for the Pneumocystis ribozyme, P10 helix formation has been shown to
aid in binding the 3’ exon region of TES substrates (18). Second, the 3’-end of each
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ribozyme sequence was modified to resemble the Pneumocystis ribozyme (see Chapter
3), including the addition of a terminal guanosine as it is required as the intramolecular
nucleophile in the substrate cleavage reaction (Chapter 3).
TES Reactions Conducted with the Pneumocystis, Tetrahymena, and Candida Ribozymes.
As a control, the TES reaction using the previously characterized Pneumocystis
(rPC) ribozyme (8) was run (Figure 5.2). TES reactions conducted with 5’-end
radiolabeled substrate (5’AUGACUGCUC3’, underlined nucleotides are excised in TES
reactions) resulted in the expected 9-mer product (5’AUGACUCUC3’) and 6-mer
intermediate (5’AUGACU3’) (Figure 5.3A, Lanes G-H). TES reaction conditions were
optimized for magnesium concentration, time, and ribozyme concentration for maximum
TES product yields (Figure 5.3B). Optimized TES reaction conditions resulted in 68.5 ±
4.4% TES product yield, with an observed rate constant, kobs, of 5.0 ± 1.1 min-1 for
substrate cleavage and 3.2 ± 0.1 min-1 for exon ligation. Note, optimized TES reactions
conditions are compiled in Table 5.1.
For the Tetrahymena (rT-X) ribozyme, TES reactions conducted with 5’-end
radiolabeled substrate (5’CUCUCUGAAAGGU3’, underlined nucleotides are excised in
TES reactions) resulted in the predicted 12-mer product (5’CUCUCUAAAGGU3’) and 6mer intermediate (5’CUCUCU3’) (Figure 5.4A, Lanes G-H). Optimized TES reactions
resulted in 47.5 ± 0.2% TES product yield (Figure 5.4B), with an observed rate constant,
kobs, of 0.17 ± 0.05 min-1 for substrate cleavage and 0.14 ± 0.02 min-1 for the exon
ligation (Table 5.1).
For the Candida (rC) ribozyme, TES reactions conducted with 5’-end
radiolabeled substrate (5’GACUCUGCUUA3’, underlined nucleotides are excised in TES
reactions) resulted in the predicted 10-mer product (5’GACUCUCUUA3’) and 6-mer
intermediate (5’GACUCU3’) (Figure 5.5A, Lanes G-H). Optimized TES reactions
conditions resulted in 50 ± 1.3% TES product yield (Figure 5.5B), with an observed rate
constant, kobs, of 0.31 ± 0.01 min-1 for substrate cleavage reaction and 0.34 ± 0.03 min-1
for exon ligation (Table 5.1). These results demonstrate that the Tetrahymena and
Candida ribozymes can catalyze the excision of a single nucleotide from within their
ribozyme-specific substrates, through the TES reaction.
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The Tetrahymena and Candida Ribozymes Catalyze the Substrate Cleavage Reaction
through Intramolecular Transesterification.
In the absence of an exogenous guanosine cofactor, the substrate cleavage
reaction can be catalyzed through two distinct reaction mechanisms. These include
ribozyme-mediated 5’ hydrolysis (12, 16) and intramolecular transesterification (13, 15,
17, 68). For the Pneumocystis ribozyme, the 3’ terminal guanosine catalyzes substrate
cleavage through an intramolecular transesterification reaction (see Chapter 3). Given
that the Tetrahymena and Candida ribozyme constructs were synthesized with 3’
terminal guanosines, it is expected that each of these constructs will catalyze their
substrate cleavage reaction through intramolecular transesterification. With these
modifications, the two ribozymes would be predicted to catalyze substrate cleavage
through intramolecular transesterification.
As seen for the Pneumocystis ribozyme, the two substrate cleavage reaction
mechanisms can be distinguished by utilizing 3’-end radiolabeled substrates. This is
because the size of the TES reaction intermediates will differ depending upon whether
the substrate cleavage step is hydrolysis or intramolecular transesterification (Chapter 3).
For the Tetrahymena ribozyme, TES reactions were conducted with 3’-end labeled
substrate (5’CUCUCUGAAAGGUC3’), which resulted in the predicted 13-mer product
(5’CUCUCUAAAGGUC3’), as well as the predicted higher molecular weight product
band (Figure 5.4A, Lanes I-J). The absence of the predicted hydrolysis product
(5’GAAAGGUC3’), suggests the Tetrahymena ribozyme undergoes intramolecular
transesterification.
For the Candida ribozyme, TES reactions were conducted using 3’-end
radiolabeled substrate (5’GACUCUGCUUAC3’), which resulted in the predicted 11-mer
product (5’GACUCUCUUAC3’), as well as the predicted high molecular weight product
band (Figure 5.5A, Lanes I-J). Again the absence of the predicted hydrolysis product (6mer,

5’

GCUUAC3’), suggests that the Candida ribozyme catalyzes substrate cleavage

through intramolecular transesterification.
As a control, TES reactions were conducted with the Pneumocystis ribozyme
using 3’-end labeled substrate (5’AUGACUGCUCC3’). TES reactions resulted in the
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expected 12-mer product (5’AUGACUCUCC3’) and the expected high molecular weight
product band (Figure 5.3A, lanes I-J).
Competition Between Exogenous Guanosine and Endogenous Guanosine for the GBS
Inhibits the TES Reaction.
Apparently, the Tetrahymena and Candida ribozymes catalyze the substrate
cleavage reaction through an intramolecular transesterification reaction mechanism. The
Pneumocystis ribozyme catalyzes the substrate cleavage reaction ~20-fold faster,
however, than either the Tetrahymena or Candida ribozyme (see Table 5.1). This
observed decrease in rate could be directly related to the ribozymes’ ability to utilize their
3’ terminal guanosines for substrate cleavage. For a previously described Tetrahymena
ribozyme (17), competition assays using exogenous guanosine, were used as a probe for
the ribozymes ability to productively bind their terminal guanosine. In these assays, the
exogenous guanosine can compete with the ribozymes terminal guanosine for binding to
the GBS. Using a similar strategy, inhibition of TES product formation could be directly
correlated to the ribozymes ability to effectively bind its terminal guanosine into the
GBS.
For the Pneumocystis ribozyme, TES reactions were conducted with increasing
concentrations of rGTP under optimal TES reaction conditions (Table 5.1). The results
demonstrate that TES product formation is not completely hindered until excessively
high concentrations of rGTP (10 mM) are added (Figure 5.3C). For the Tetrahymena
ribozyme, TES reactions resulted in complete inhibition of TES product formation at
much lower rGTP concentrations (0.02 mM) (Figure 5.4C). In the case of the Candida
ribozyme, TES reactions demonstrate that low concentrations of rGTP (0.04 mM) are
also effective at completely hindering TES product formation (Figure 5.5C). These
results suggest that the Pneumocystis ribozyme binds its terminal guanosine (G336) more
effectively than either the predicted terminal guanosine of the Tetrahymena ribozyme
(G416) or the Candida ribozyme (G374).
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DISCUSSION
In this report, group I intron-derived ribozymes from Tetrahymena and Candida
were shown to be capable of catalyzing the excision of internal segments (in this case a
single nucleotide) from within their native 5’ and 3’ exon sequences. Furthermore, the
Tetrahymena and Candida ribozyme constructs were shown to catalyze the substrate
cleavage reaction through an intramolecular transesterification mechanism, using their
predicted 3’ terminal guanosines as the nucleophiles. This is the first report that group I
intron-derived ribozymes other than Pneumocystis can catalyze the excision of internal
segments from RNA transcripts via the TES reaction.
The Tetrahymena Ribozyme
The Tetrahymena and Pneumocystis ribozymes catalyze the individual steps of
the TES reaction under similar optimized magnesium, time, and ribozyme conditions (see
Table 5.1). The results, however, show that the Pneumocystis ribozyme catalyzes the
individual steps of the TES reaction with higher yields than the Tetrahymena ribozyme.
Furthermore, the Pneumocystis ribozyme catalyzes substrate cleavage ~30-fold faster
than the Tetrahymena ribozyme (Table 5.1). In addition, the Pneumocystis ribozyme
catalyzes exon ligation ~20-fold faster than the Tetrahymena ribozyme.
One reason that could explain the differences seen for the Tetrahymena and
Pneumocystis ribozymes is that additional nucleotides, other than guanosine, are being
added to the 3’-end of these ribozymes during in vitro transcription. The non-encoded
addition of nucleotides to the 3’-end of RNA transcripts has previously been shown to be
a consequence of run-off transcription utilizing T7 RNA polymerase (92). The
Pneumocystis ribozyme, however, has been shown to catalyze its own 3’-end activation,
which would result in the removal of these additional nucleotides (see Chapter 3). In
contrast, previously characterized Tetrahymena ribozymes that catalyze intramolecular
transesterification reactions had to be activated by subjecting the ribozyme to a sitespecific 3’ hydrolysis reaction (13, 15, 17, 97). It is unknown whether this pre-activation,
which is not necessary for Pneumocystis, would have aided in the Tetrahymena reaction.
Therefore, the Tetrahymena ribozyme may be hindered in its ability to catalyze site-
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specific 3’ hydrolysis reactions under the prevailing TES reaction conditions, which
could lead to a lower population of active ribozyme.
Alternatively, or in addition, the Tetrahymena ribozyme may catalyze reactions
different from TES. For instance, a higher molecular weight product band is present with
TES reactions conducted with 5’-end labeled substrates (Figure 5.4A). This high
molecular weight product band is predicted to be the result of a previously characterized
ribozyme-mediated reverse-splicing reaction (79, 80). In this reaction, the ribozyme
becomes embedded between the 5’ and 3’ exon regions of its RNA substrate. Note that
this higher molecular weight product band is absent for TES reactions conducted with the
Pneumocystis ribozyme. That the Tetrahymena ribozyme can potentially catalyze this
reaction is due to the addition of a guanosine to the 5’-end of the ribozyme coding
sequence (added to facilitate efficient in vitro transcription). If in fact the reverse-splicing
is occurring, then two competing reactions (TES and reverse-splicing) will
simultaneously be occurring, which could explain the lower efficiency of the
Tetrahymena ribozyme reactions.
In addition, previously characterized Tetrahymena ribozymes (68, 69, 142), which
closely resemble our Tetrahymena ribozyme construct, are susceptible to both hydrolysis
and intramolecular cyclization reactions in the absence of substrate (68, 69, 142). Both of
these reactions result in either a truncated or circular ribozyme product (68, 69, 142). If
either of these reactions is occurring, the result would be a reduction of fully functional
Tetrahymena ribozyme. Although, we have no evidence for these alternative reactions,
they could be occurring in small amounts, which would partially explain the lower
efficiency for the Tetrahymena ribozyme reactions.
The Candida Ribozyme
The Candida and Pneumocystis ribozymes catalyze the individual steps of the
TES reaction under similar optimized time and ribozyme conditions (Table 5.1). For the
Candida ribozyme, however, higher magnesium concentrations are required for optimal
TES reactivity. Similar to the Tetrahymena ribozyme, the Candida ribozyme was
observed to catalyze the individual steps of the TES reaction with lower yields than the
Pneumocystis ribozyme. Moreover, the Candida ribozyme catalyzes substrate cleavage
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~15-fold slower than the Pneumocystis ribozyme (Table 5.1). In addition, the Candida
ribozyme catalyzes exon ligation ~10-fold slower than the Candida ribozyme.
As for the Tetrahymena ribozyme, it is not known if a substantial percentage of
the population of Candida ribozymes terminates in guanosine. Similarly, it is not known
if the Candida ribozyme can catalyze a site-specific 3’ hydrolysis reaction prior to
becoming activated. If the Candida ribozyme is not being activated under prevailing TES
reaction conditions, this could explain the lower efficiency of the Candida ribozyme
reactions.
Lastly, the Candida ribozyme produces a high molecular weight product band,
similar to Tetrahymena ribozyme, for TES reactions conducted with 5’-end labeled
substrates (Figure 5.5A). At higher magnesium concentrations, the amount of this high
molecular weight product band increases with increasing magnesium concentrations. As
stated above, if in fact TES and reverse-splicing are simultaneously occurring then the
lower efficiency observed for the Candida ribozyme would be predicted.
Productive Docking of the 3’ Terminal Guanosine Effects the Overall TES Reaction.
Prior to the substrate cleavage reaction, it is predicted that the ribozymes 3’
terminal guanosine will be bound into the GBS (17, 68). From the competition studies, it
appears that the terminal guanosine of the Pneumocystis ribozyme is more productively
bound to the GBS than the Tetrahymena or Candida ribozymes. These results suggest
that the decrease in binding affinity of the Tetrahymena and Candida ribozymes is
possibly due to their inability to bind the terminal guanosine into the GBS. This is
surprising in that the 3’-end of the ribozyme constructs are all similar.
As seen for ribozyme-mediated intramolecular transesterification reactions, the 3’
terminal guanosine is predicted to be aligned into the GBS through helix P9.0 (17, 68).
For example, a previously described Tetrahymena ribozyme, L21-G414, was predicted to
align its 3’ terminal guanosine into the GBS through the aid of P9.0 helix formation (17).
For L21-G414 ribozyme construct, the sequence at the 3’-end of the ribozyme was
identical to the native intron sequence, thereby allowing the two nucleotides preceding
the terminal guanosine to be involved in P9.0 helix formation. For our studies, however,
the 3’ terminal sequence of the Tetrahymena and Candida ribozymes were modified to
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resemble the Pneumocystis ribozyme. These modifications were made to allow direct
comparisons between the individual ribozyme constructs and because P9.0 was shown
not to be required (19). As a result, the sequences preceding the terminal guanosine are
not predicted to form the P9.0 helix. Therefore, to enhance the ωG binding affinity of the
Tetrahymena and Candida ribozymes, one strategy to try might be to modify the 3’
sequence back to the native intron sequence. Nevertheless, our results demonstrate that
all three constructs, in their current incarnations, effectively catalyze the TES reaction.
Comparison with Previous Results
A previously characterized Tetrahymena ribozyme that lacks both the 5’ and 3’
exon sequences and the RE1 and RE3 sequences is capable of catalyzing a TES-like
reaction (143). This highly truncated Tetrahymena ribozyme was shown to be capable of
binding pseudoknot structures in trans resulting in the formation of P1 and P10 helices.
For TES ribozymes, the individual ribozyme constructs contain the nucleotides required
for the P1 and P10 helices. Unlike the TES reaction, this reaction requires high
magnesium concentrations (10-100 mM), high temperatures (55-65 °C), and an
exogenous guanosine cofactor. For our studies, TES reactions conducted with the
individual ribozymes were optimized at lower magnesium concentrations (10-25 mM) at
lower temperatures (44 °C), and do not require an exogenous guanosine cofactor.
Most recently, an engineered twin ribozyme has been shown to mediate the
excision of an internal segment from within an RNA substrate (144). In this reaction,
excision is mediated by an exchange reaction, consisting of two cleavage and two ligation
reactions. In addition, two RNA substrates are required for the twin ribozyme approach,
whereas for TES only one substrate is required. The reaction conditions for the twin
ribozyme reaction are similar to TES conditions, however, prohibitively long incubation
times (8 h) are required as compared to 30-45 min for TES. Furthermore, the product
yield for the twin ribozyme-mediated excision reaction is considerably lower (17%) than
we get with TES reactions conducted with Pneumocystis ribozyme (68%).
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Table 5.1. Optimized TES reaction conditions for the Pneumocystis, Tetrahymena, and Candida
ribozyme constructs
Optimized TES reactions conditionsa
TES product yield and observed rate
constants for substrate cleavage and exon
ligation reactionsb
MgCl2
(mM)

Time
(min)

Ribozyme
(nM)

TES product
(%)

Substrate
Cleavage
(kobs min-1)

Exon
Ligation
(kobs min-1)

Pneumocystis

15

30

100

68.5 ± 4.4

5.0 ± 1.1

3.2 ± 0.1

Tetrahymena

10

45

166

47.5 ± 0.18

0.17 ± 0.05

0.14 ± 0.02

Candida

25

30

75

50.0 ± 1.5

0.31 ± 0.01

0.34 ± 0.03

a

The individual ribozyme constructs were optimized for magnesium concentration, time, and
ribozyme concentration for maximum TES product yields. bThe observed rate constants, kobs,
were obtained for the substrate cleavage and exon ligation reactions under single turnover
conditions.
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Trans Excision-Splicing Reaction
TES Substrate
5’

5’ Exon

3’ Exon
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Nucleophilic attack by
terminal guanosine (G336)
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(RE1)

Ribozyme

3’ Exon
(RE3)

3’
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5’

Bridge
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Figure 5.1. Diagram of the ribozyme-mediated trans excision-splicing reaction. The
Pneumocystis carinii ribozyme is denoted in gray lines and the 5’ and 3’ exon sequences
are denoted by black lines. The black square within the 5’ exon region denotes a uridine
and the gray circle adjacent to the 3’ exon region denotes a guanosine (ωG). The bridge
region, to be excised, is denoted as a dotted line. The P1 helix is formed through basepairing of recognition element 1 (RE1) with the 5’ exon. The P10 helix is formed through
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base-pairing of recognition element 3 (RE3) with the 3’ exon. The first step (substrate
cleavage) is catalyzed by G336 (open circle at 3’-end of ribozyme) resulting in the
covalent attachment of the 3’-end of the substrate to the 3’-end of the ribozyme. The
second step (exon ligation) proceeds through attack of the uridine upon the ωG of the
substrate, resulting in ligation of the flanking sequences. Note that the product of the TES
reaction is that ωG (of substrate) remains attached to the 3’-end of the ribozyme.
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Figure 5.2. Diagram of Pneumocystis carinii (rPC), Tetrahymena thermophila (rT-X),
and C. albicans (rC) ribozyme constructs. The sequence P. carinii, T. thermophila, and
C. albicans ribozyme constructs are shown in uppercase letters with their respective
substrate shown in lowercase letters. Note, only the sequences that are involved with
binding the individual substrates are shown. The remaining ribozyme sequences,
represented with a line, are different for each of the constructs. The nucleotide to be
excised (ωG) is circled for all three ribozyme constructs.
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Figure 5.3. TES reactions conducted with the Pneumocystis carinii (rPC) ribozyme. A.
Polyacrylamide gel representing substrates and products from TES reactions using both
5’ and 3’-end radiolabeled substrates using 100 nM rPC, 15 mM MgCl2, at 30 min at 44
°C. Lanes A, C, and E contain 5’-end radiolabeled 10-mer, 9-mer, and 6-mer size
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controls. Lanes B, D, and F contain 3’-end radiolabeled 10-mer, 9-mer, and 4-mer size
controls. Note that the 3’-end radiolabeled size controls are one nucleotide larger than 5’end radiolabeled size controls. Gel lanes containing a plus (+) sign show reactions
conducted in H15Mg and lanes containing a minus (-) sign show reactions conducted in
H0Mg. Lanes G-J contain the normal rPC ribozyme with 5’-end radiolabeled 13-mer
(lanes G and H) or 3’-end radiolabeled 13-mer (lanes I and J). B. Graphs of optimization
of TES reactions using 5’-end radiolabeled 13-mer substrate for magnesium
concentration, time, and ribozyme concentration. All reactions were conducted as above
except for the changing variable. C. Graph of rGTP concentration dependence for TES
reactions conducted with the rPC ribozyme. All data points represent the average of at
least two independent reactions, with standard deviations typically below 10%. Note for
all graphs, the 9-mer TES product is represented by filled circles and the substrate
cleavage product, 6-mer, is represented as open circles.
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Figure 5.4. TES reactions conducted with the Tetrahymena thermophila (rT-X) ribozyme.
A. Polyacrylamide gel representing substrates and products from TES reactions using
both 5’ and 3’-end radiolabeled substrates using 166 nM rT-X, 10 mM MgCl2, at 45 min
at 44 °C. Lanes A, C, and F contain 5’-end radiolabeled 13-mer, 12-mer, and 6-mer size
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controls. Lanes B, D, and E contain 3’-end radiolabeled 13-mer, 12-mer, and 7-mer size
controls. Note that the 3’-end radiolabeled size controls are one nucleotide larger than 5’end radiolabeled size controls. Gel lanes containing a plus (+) sign show reactions
conducted in H10Mg and lanes containing a minus (-) sign show reactions conducted in
H0Mg. Lanes G-J contain the normal rT-X ribozyme with 5’-end radiolabeled 10-mer
(lanes G and H) or 3’-end radiolabeled 10-mer (lanes I and J). B. Graphs of optimization
of TES reactions using 5’-end radiolabeled 13-mer substrate for magnesium
concentration, time, and ribozyme concentration. All reactions were conducted as above
except for the changing variable. C. Graph of rGTP concentration dependence for TES
reactions conducted with the rT-X ribozyme. The data represents the average of at least
two independent reactions, with standard deviations typically below 10%. All data points
represent the average of at least two independent reactions with standard deviations
typically below 10%. Note for all graphs, the 12-mer TES product is represented by filled
triangles and the substrate cleavage product, 6-mer, is represented as open triangles.
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Figure 5.5. TES reactions conducted with the Candida albicans (rC) ribozyme. A.
Polyacrylamide gel representing substrates and products from TES reactions using both
5’ and 3’-end radiolabeled substrates using 75 nM rC, 25 mM MgCl2, at 30 min at 44 °C.
Lanes A, C, and E contain 5’-end radiolabeled 11-mer, 10-mer, and 6-mer size controls.
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Lanes B, D, and F contain 3’-end radiolabeled 11-mer, 10-mer, and 5-mer size controls.
Note that the 3’-end radiolabeled size controls are one nucleotide larger than 5’-end
radiolabeled size controls. Gel lanes containing a plus (+) sign show reactions conducted
in H25Mg and lanes containing a minus (-) sign show reactions conducted in H0Mg.
Lanes G-J contain the normal rC ribozyme with 5’-end radiolabeled 10-mer (lanes G and
H) or 3’-end radiolabeled 10-mer (lanes I and J). B. Graphs of optimization of TES
reactions using 5’-end radiolabeled 11-mer substrate for magnesium concentration, time,
and ribozyme concentration. All reactions were conducted as above except for the
changing variable. C. Graph of rGTP concentration dependence for TES reactions
conducted with the rC ribozyme. All data points represent the average of at least two
independent reactions, with standard deviations typically below 10%. Note for all graphs,
the 11-mer TES product is represented by filled triangles and the substrate cleavage
product, 6-mer, is represented as open triangles.
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CHAPTER SIX-INSERTION OF MODIFIED OLIGORIBONUCLEOTIDES
UITLIZING THE TRANS INSERTION-SPLICING REACTION
INTRODUCTION
The site-specific modification of RNA, specifically the incorporation of modified
nucleotides, has greatly increased our fundamental understanding of RNA structure and
function (145-147). To date, several strategies have been developed for the site-specific
alteration of RNA, including the addition of a modified nucleotide(s) (148-157). These
include the chemical synthesis of RNA using existing phosphoramidite strategies. In
addition, chemical and enzymatic ligation strategies have been developed, which take
advantage of the unique properties of the termini of RNA (148-150). Strategies
substituting modified nucleosides or using unnatural base-pair combinations during in
vitro transcription reactions have also been developed (151-155). Furthermore, a twin
ribozyme was engineered to replace an internal segment of RNA with a modified
nucleotide (156). Most recently, a deoxyribozyme was engineered for the insertion of
modified nucleotides (157). In some cases, however, existing strategies suffer from a lack
of product specificity, low product yields, long reaction times, and are limited by the
types of modified nucleotides that can be incorporated.
The trans insertion-splicing (TIS) reaction, catalyzed by a group I intron-derived
ribozyme from Pneumocystis carinii (P. carinii), was recently developed to sequencespecifically insert a predefined RNA sequence into a target RNA substrate (10). The TIS
reaction, which utilizes two separate RNA substrates, has been proposed to proceed
through three separate chemical steps. These include two consecutive substrate cleavage
steps and a single exon ligation step (Figure 6.1).
To increase the general applicability of the TIS reaction, TIS was investigated as a
new strategy for the insertion of modified oligonucleotides. Four modified
oligonucleotides were designed to test modifications at either the 2’ position of the sugar
ring (deoxy), the phosphodiester backbone (phosphothioate), or the base (2-aminopurine
or 4-thiouridine) position. All four modified oligonucleotides were shown to be inserted
sequence-specifically within their intended target. In addition, a doubly modified
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oligonucleotide, including a methoxy and deoxy substitution, was shown to be an
effective substrate for the insertion of multiple modified oligonucleotides. The results
demonstrate TIS as an alternative strategy for the insertion of modified nucleotides into
RNA, including multiple modified nucleotides. The TIS strategy could potentially lead to
a more effective method for the creation of full-length RNA transcripts containing these
site-specific modifications.
MATERIALS AND METHODS
Oligonucleotide Synthesis and Preparation
DNA oligonucleotides were obtained from Integrated DNA Technologies
(Coralville, IA) and were used without further purification. RNA oligonucleotides were
obtained from Dharmacon Research, Inc. (Lafayette, CO) and were deprotected using the
manufacturer’s standard protocol. Concentrations of individual oligonucleotides were
calculated

from

UV

absorption

measurements

using

a

Beckman

DU

650

spectrophotometer (Beckman Coulter, Inc.; Fullerton, CA). RNA oligonucleotides were
5’-end radiolabeled by phosphorylation of the 5’ terminal hydroxyl group with [γ-32P]
ATP (Amersham Pharmacia Biotech; Piscataway, NJ) using T4 polynucleotide kinase
(New England Biolabs; Beverly, MA) as previously described (75). The sequences of the
substrates used are shown in Table 6.1.
Ribozyme Synthesis
The previously constructed PC plasmid (8) was linearized in a 50 μL reaction
consisting of 16 μg of plasmid, 1 X REACT 2 buffer, and 50 units XbaI (Invitrogen) at
37 °C for 2 h. The resulting linearized plasmid was isolated using the QIAquick PCR
purification kit (Qiagen) using the manufacturers protocol. Run-off transcription was
performed for 2 h in a 50 μL reaction consisting of 1 μg linearized DNA template, 50
units of T7 RNA polymerase (New England Biolabs; Beverly, MA), 40 mM Tris-HCl
(pH 7.5), 10 mM MgCl2, 5 mM DTT, 5 mM spermidine, and 1 mM rNTPs. The rPC
ribozyme was purified using a Qiagen Plasmid Midi Kit (Qiagen), as previously
described (8). Ribozyme concentrations were calculated from UV absorption
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measurements using a Beckman DU 650 spectrophotometer (Beckman Coulter, Inc).
TIS Reactions
TIS reactions were conducted under previously optimized reaction conditions
using the rPC ribozyme (9). Briefly, a 5.0 μL ribozyme solution consisting of 240 nM
rPC in H10Mg (50 mM HEPES (25 mM Na+). 135 mM KCl, and 10 mM MgCl2 at pH
7.5) was pre-incubated at 60 °C for 5 min followed by slow cooling to 44 °C. A separate
solution consisting of 6 nM 5’-end radiolabeled TIS substrate (5’AUGACUAAACAU3’)
and 30 μM of the individual TIS inserts (5’GCUCUCGUG3’, underlined nucleotides
denote the sites of modification) in H10Mg was pre-incubated at 44 °C. TIS reactions
were initiated by the addition of 1.0 μL of the precombined TIS donor and acceptor
substrates to the ribozyme solution. This results in a final concentration of 200 nM rPC
ribozyme, 1.0 nM TIS acceptor substrate, and 1.0 μM TIS donor substrate. TIS reactions
were conducted for 2 h at 44 °C, at which time the reaction was terminated by addition of
an equal volume (6 μL) of a 2X stop buffer (10 M urea, 3 mM EDTA, and 0.1X TBE).
The reaction mixture was denatured for 1 min at 90 °C and separated on a 12%
polyacrylamide/8 M urea gel. The gel was transferred to chromatography paper and dried
under vacuum. The bands were visualized and quantified on a Molecular Dynamics
Storm 860 Phosphorimager.
RESULTS
Design of the TIS Test System
It has previously been shown that a group I intron-derived ribozyme from P.
carinii (rPC) can catalyze the TIS reaction, as shown in Figure 6.1 (9). For these previous
studies, the sequence of the ribozyme was kept intact, albeit truncated, and the donor and
acceptor substrates closely mimicked the ribozymes native 5’ and 3’ exon sequences.
Maintaining these sequences was important in order to maximize the binding and
subsequent reactivity of the tri-component system during the original proof-of-concept
study (10). Therefore, the same ribozyme and substrate sequences were used in this
study, except for the nucleotide analog substitutions at positions 6-8 (Figure 6.1) within
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the TIS donor substrate (see Table 6.1). Though positions 6-8 are involved in binding and
subsequent alignment of TIS substrates, through molecular interactions with the
ribozyme, these sites were chosen as they would be expected to have the least deleterious
effect upon the TIS reaction (Figure 6.2). To determine the generality of the method,
nucleotides that contain sugar, phosphate, and nucleobase modifications were analyzed.
These include deoxyribose (dG), methoxyribose (mU), phosphorothioate (SH), 2aminopurine (2AP), and 4-thiouridine (4SU) substitutions (Table 6.1). Note that for each
of the donor substrates, the same sized TIS product is expected to form, which is the
same size as that with the previously sequenced unmodified substrate (10).
TIS Insertion of Modified Oligoribonucleotides
TIS reactions were conducted as previously described (10), under previously
optimized reaction conditions (see Figure 6.3 legend). Substrates, intermediates, and
products of each of the individual TIS reactions were separated and visualized via
polyacrylamide gel electrophoresis. The initial reactions focused on modifications only at
position 7, as this was expected to be least disruptive to the reaction. As shown in Figure
6.3, each of the four substrates modified at position 7 resulted in the expected 18-mer
product band (Lanes F-J). Note that the relatively small size differences between the TIS
products are due to different modifications within the substrates. Apparently, position 7
of the donor substrate is readily modifiable; resulting in the effective insertion of
modified RNAs into other RNAs (see reaction yields in Table 6.2). At position 7, the
deoxy (Figure 6.3, lane G) and phosphothioate (Figure 6.3, lane H) substitutions were
essentially as effective as the non-modified substrate (Figure 6.3, lane F). TIS product
yields for the deoxy was 72 ± 0.8% and 65 ± 0.2% for the phosphothioate, compared to
68 ± 1.8% for the non-modified substrate (Table 6.2). Lower, although comparable,
yields (59 ± 0.9% versus 63 ± 0.3%) were obtained for the two nucleobase modifications
(Figure 6.3, lanes I and J). This result suggests that base modifications do hinder TIS
product formation, most probably through interrupting structural elements within the rPC
ribozyme utilized during the course of the reaction. Note that the faint second product
band for TIS reactions conducted with the 4-thiouridine TIS donor substrate (Figure 6.3,
lane J) is potentially due to degradation of the starting material.
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It was then tested whether more than one modification could be added to the
donor substrate. Positions 6 and 8 were analyzed to see if they too could be modified (in
addition to position 7), and different modifications, including a methoxy substitution and
a deoxy substitution, were chosen to broaden the potential applicability of the method. As
shown in Figure 6.3 (Lane K), the doubly modified donor substrate is as effective a TIS
substrate (75 ± 0.9% product) as its non-modified counterpart. Apparently, the 2’ position
of the ribose at positions 6 and 8 (in addition to position 7) of the donor substrate are sites
that can be readily modified. This result shows that the TIS reaction is an effective
strategy for the insertion of multiple modifications within an RNA transcript. Taken
together, these results demonstrate that the TIS reaction can be exploited for inserting
non-native, chemically modified oligonucleotides into RNAs in trans.
DISCUSSION
In this study, it has been demonstrated that the trans insertion-splicing ribozyme
from P. carinii can utilize substrates that contain modifications, and that this activity can
be exploited to generate RNAs with one or more internal modifications. In this study, the
functional group modifications within the sugar phosphate backbone at position 7 of the
donor substrate (see Figure 6.2) have been shown to not hinder the TIS reaction. In
contrast, nucleobase modifications at position 7 do reduce TIS yields, although not by
prohibitive amounts (approximately 15% reduction). These results suggest that disruption
of the P9.0 helix interaction between this nucleobase and the ribozyme during the second
TIS reaction step is not prohibitive (see Figure 6.1). Therefore, the TIS reaction is a
relatively effective method for synthesizing RNAs that contain sugar-phosphate
backbone and nucleobase modifications.
Like that at position 7, ribose modifications at donor substrate positions 6 and 8
also do not reduce TIS yields. Apparently, the 2’ OH groups at positions 6, 7, and 8 are
expendable for the TIS reaction, which enhances the flexibility of using TIS as a
synthetic tool. In addition, that the TIS reaction conducted with the doubly-modified
donor substrate was successful demonstrates that TIS is an effective strategy for the
insertion of multiple modified nucleotides within a given RNA sequence.

107

While the products of the TIS reactions in this proof-of-concept study are short
enough to have been synthesized chemically in high yields, chemically synthesizing large
RNAs, with or without modifications, is prohibitive due to insufficient expected yields. It
is envisioned that the TIS reaction could be exploited for the synthesis of large, sitespecifically modified RNAs. This could be accomplished using TIS to insert a small,
chemically synthesized RNA (acting as the donor molecule, modified at a position
corresponding to positions 6, 7, or 8 in Figure 6.1) into a full-length RNA transcript
(acting as the acceptor substrate). Note that in terms of ribozyme design, all of the
ribozyme and substrate sequences that make up the molecular recognition elements can
be altered as desired to create appropriate target-substrate combinations, as long as the
substrate-ribozyme base pairs shown in Figure 6.1 are maintained. In addition, it is
expected that full-length transcripts could be effective TIS acceptor substrates because a
similar ribozyme, acting as a trans excision-splicing (TES) catalyst, has already been
shown to be active on a full-length GFP transcript in vivo (10).
Comparison with Previously Developed Methods
Enzymatic methods have previously been developed for the incorporation of
modified nucleotides into large RNAs. One strategy is to add the desired modified
nucleotide precursor directly into transcription reactions conducted in vitro (151, 152).
Although this strategy can be quite effective and useful, it is not appropriate for
synthesizing single site-specific RNAs, as the modified nucleotides are incorporated
throughout the entire transcript. Another strategy solves this problem by utilizing unique
non-native nucleotides in the transcription template that only pair with other unique RNA
nucleotides, thus forming RNAs during transcription that have non-native nucleotides
incorporated (153-155). Unfortunately, the numbers of non-native nucleotides that can
be used in this strategy is extremely limiting. In comparison, the TIS strategy could
potentially be simpler to design and enact, and is not entirely dependent on the secondary
structure formation properties of the modified nucleotide(s) for the success of the
method.
The enzymatic ligation of separately synthesized RNAs, including RNAs that
contain modifications, using either RNA or DNA ligases (149, 150, 158-161) have been
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the most widely used methods for constructing large modified RNAs. Though these
methods have been quite successful, in some instances, they still suffer from low product
yields and long reaction times. In addition, the substrates that are used in enzymatic
ligation methods are typically transcript length, which requires highly precise synthetic,
purification, and ligation methods. In contrast, the TIS method requires the ribozyme
(whose sequence has been designed for the particular application), one transcript, and a
synthetic modified RNA.
Recently, the site-specific modification of RNA has been accomplished using an
engineered dual hairpin ribozyme, termed a twin ribozyme (156). In this strategy, the
ribozyme can replace an internal segment of an RNA transcript with a separate RNA
which may or may not contain a modification. This method shares many similarities to
the TIS reaction, including using a catalytic RNA and two exogenous RNA substrates.
Nevertheless, the two methods differ by the type of the ribozyme (hairpin versus group I
introns), the required sequence elements in the substrates, the catalytic mechanisms, and
the optimal reaction conditions. The TIS strategy, however, results in higher product
yields than the twin ribozyme approach (70% versus 20% product yield), which suggests
that the TIS strategy could be more efficient at inserting modified oligonucleotides into
RNA transcripts (156).

Copyright © Perry Patrick Dotson II 2008
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Table 6.1. TIS starting material and insert substrate sequences.
TIS Acceptor Substrate
12-mer-starting material

Sequence
5’

AUGACUAAAGAU3’

Unmodified TIS Donor Substrate

Sequence
5’

9-mer-unmodified insert

GCUCUCGUG3’

Modified TIS Donor Substrate

Sequence

9-mer-deoxyguanosine (dG)
9-mer-phosphothioate (SH)
9-mer-2-aminopurine (2AP)
9-mer-4-thiouridine (4SU)
9-mer-doubly modified (DM)

GGUCUC(dG)UG3’
GGUCUC(SH)GUG3’
5’
GGUCUC(2AP)UG3’
5’
GGUCUC(4SU)UG3’
5’
GGUCU(dC)G(mU)G3’

5’

5’

The sequences for the TIS acceptor substrate (12-mer), normal
(unmodified) TIS donor substrate (9-mer), and modified TIS
donor substrates (9-mer) are shown. For both the unmodified
and modified TIS donor substrates the sequences to be inserted
are highlighted in gray. For each modified TIS donor substrate
the modified nucleotide (located at either position C6, G7, or
U8) is shown in parentheses. The modified TIS donor
substrates include a deoxyguanosine or deoxycytosine (dG or
dC), phosphothioate (SH), 2-aminopurine (2AP), 4-thiouridine
(4SU), or methoxyuridine (mU) substitution.
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Table 6.2. Percent TIS product formation for individual modified oligonucleotides.
Predicted TIS Product Sequencea
(18-mer)

TIS Donor Substrate

5’

9-mer-normal insert
5’

9-mer-deoxyguanosine (dG)
9-mer-phosphothioate (SH)

5’

9-mer-2-aminopurine (2AP)

5’

9-mer-4-thiouridine (4SU)

5’

9-mer-doubly modified (DM)

5’

TIS Productb

AUGACUCUCGUGAAACAU3’

68±1.8%
3’

AUGACUCUC(dG)UGAAACAU

72±0.8%

AUGACUCUC(SH)GUGAAACAU3’

59±0.9%

3’

63±0.3%

AUGACUCUC(2AP)UGAAACAU
AUGACUCUC(4SU)UGAAACAU

3’

AUGACUCU(dC)G(mU)GAAACAU

a

65±0.2%

3’

75±0.9%

Predicted TIS product (18-mer) for TIS reactions conducted with the TIS acceptor substrate
(12-mer) and either the unmodified or modified TIS donor substrates. The sequences
highlighted in gray represent the insert region including the modified nucleotide(s). TIS
reactions were conducted under previously optimized reaction conditions (200 nM ribozyme,
10 mM MgCl2, 1 μM insert at 44 °C for 2 hr). bPercent TIS product (18-mer) formed using
each
of
the
modified
oligonucleotide
substrates.
The
TIS
product,
5’
AUGACUCUCGUGAAACAU3’, includes modification at either the C6, G7, or U8
positions (shown in parentheses) from the TIS donor substrate.
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Figure 6.1. Schematic representation of the TIS reaction model system. The
Pneumocystis carinii (rPC) ribozyme is shown in black uppercase lettering including the
ribozyme recognition elements; RE1, RE2, and RE3 that form the P1, P9.0, and P10
helices respectively. The 9-mer TIS donor substrate (5’G1C2U3C4U5C6G7U8G93’) is shown
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in both blue lettering (5’ exon region) and red lettering (insert region). The guanosine at
the 3’ terminal end of the insert region represents ωGi. The 12-mer TIS acceptor
substrate (5’AUGACUAAACAU3’) is shown in black lowercase lettering. The TIS donor
substrate forms the P1i and P10 helices through RE1 and RE3 of the ribozyme. The 3’
terminal guanosine (G336) of the ribozyme performs a nucleophilic attack upon the 5’
splice site, resulting in the covalent attachment of the insert region to the 3’-end of the
ribozyme. The 5’ exon region of the TIS donor substrate dissociates from the ribozyme,
and the TIS acceptor substrate is bound through a second P1 helix. The ωGi (aligned by
P9.0 helix formation) performs a nucleophilic attack upon the 5’ splice site in the TIS
acceptor substrate, resulting in the covalent attachment of the 3’ exon region of the TIS
acceptor substrate to the 3’-end of the ribozyme. Exon ligation proceeds through the
nucleophilic attack of the uridine at the 3’-end of 5’ exon region of the TIS substrate
upon G336 of the ribozyme, resulting in the final TIS product (18-mer,
5’

AUGACUC4U5C6G7U8G9AAACAU3’).
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Figure 6.2. Diagram of the modified nucleotides and naming conventions used in this
study. The normal nucleotide at position 6, 7, and 8 within the TIS donor substrate (9mer, 5’G1C2U3C4U5C6G7U8G93’) are shown in addition to the individual modifications to
the 2’ position of the sugar ring [deoxycytosine (dC), deoxyguanosine (dG), and
methoxyuridine (mU)], the phosphodiester backbone [phosphothioate (SH)], and base
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position [2-aminopurine (2AP) and 4-thiouridine (4SU)]. Note each individual
modification is depicted with a circle.
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6-mer

A

B

C
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(-) (N) (dG) (SH) (2AP) (4SU) (DM)

Figure 6.3. Polyacrylamide gel showing substrates, intermediates, and products of the
trans insertion-splicing reaction. Reactions were conducted with 200 nM ribozyme, 1 nM
acceptor substrate, and 1 μM donor substrate in H10Mg at 44 °C for 2 h. Lanes A, B, and
C contain 5’-end radiolabeled 18-mer, 12-mer, and 6-mer size controls respectively.
Negative control lanes (-) consist of reactions run in H0Mg buffer (Lane D) or without
rPC ribozyme (Lane E). Lane F contains the TIS reaction with the unmodified donor
substrate (N), and serves as a positive control. Lanes G, H, I, J, and K contain the TIS
reaction with deoxy (dG), phosphothioate (SH), 2-aminopurine (2AP), 4-thiouridine
(4SU), and doubly-modified (DM) substituted donor substrates, respectively.
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CHAPTER SEVEN-FUTURE DIRECTIONS
The Trans Excision-Splicing Reaction
The trans excision-splicing (TES) reaction has been envisioned as a potential
therapeutic strategy for the correction of defective RNA transcripts within a cell. In this
strategy, the Pneumocystis carinii ribozyme would be engineered to excise specific
regions from within defective RNA transcripts. The resulting corrected version of the
transcript will lead to the production of a functional protein. As seen for other ribozymemediated reactions, similar to the TES reaction, repairing as little as 10% of these
transcripts has beneficial effects for an underlying genetic mutation (85, 88). The work
presented herein has answered some of the questions relating to the TES reaction with
respect to the overall reaction mechanism.
Intramolecular Transesterification Reaction for Cleavage of TES Substrates
The work presented herein has established a mechanistic framework for the
substrate cleavage step of the TES reaction. Substrate cleavage was shown to be a
ribozyme-mediated intramolecular transesterification reaction, catalyzed by the 3’
terminal guanosine (G336) of the Pneumocystis carinii ribozyme. The direct consequence
of the intramolecular transesterification reaction is that the bridge-3’ exon region of TES
substrates will be covalently attached to the 3’-end of the Pneumocystis ribozyme. Proof
of the mechanism was obtained through sequencing of ribozyme reaction intermediates
isolated from in vitro and in vivo TES reactions. The results obtained confirmed the
presence of the expected ribozyme intermediate.
Though the mechanism for the substrate cleavage step of TES was established,
several questions arise with respect to enhancing the reactions specificity and efficiency
in vitro and in vivo. For instance, it is not known how effectively the Pneumocystis
ribozyme terminates in the required 3’ terminal guanosine. As future TES reactions will
undoubtedly be conducted in eukaryotic cell lines, enhancing the ribozymes ability to
terminate in a guanosine is critical. For instance, a Pneumocystis ribozyme, expressed
within a eukaryotic cell line (HeLa), lacking a 3’ terminal guanosine resulted in a
ribozyme incapable of catalyzing the TES reaction. To address this concern, the
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percentage of Pneumocystis ribozymes that terminate in guanosine could be obtained
through 3’ rapid amplification of cDNA ends (RACE). This strategy could be used both
in vitro and in vivo to distinguish between active and inactive forms of the Pneumocystis
ribozyme.
To date, it is unknown how effectively the 3’ terminal guanosine (G336) of the
Pneumocystis ribozyme is aligned into the guanosine binding site (GBS). If the terminal
guanosine is found to be poorly aligned into the GBS, the molecular recognition elements
of the ribozyme could be modified to enhance this alignment. Specifically, the two
nucleotides, which constitute recognition element 2 (RE2), could be altered to base-pair
with the two nucleotides preceding G336 of the ribozyme. This would lead to a P9.0
helix interaction, which has been shown to aid in the alignment of the 3’ terminal
guanosine for other ribozyme-mediated reactions (17).
If intramolecular 3’ hydrolysis is shown to be inefficient at creating the active
form of the Pneumocystis ribozyme in vivo, the ribozyme could potentially be
reengineered. This would involve including both a P9.0 and P10 helix interaction, which
could potentially increase the efficiency of the hydrolysis reaction. As Pneumocystis
ribozymes expressed in vivo will likely have transcription termination sequences defining
their 3’-ends, enhancing the intramolecular 3’ hydrolysis reaction will increase the
likelihood of successful TES reactions.
Lastly, it has been shown that the substrate cleavage reaction in vivo is not highly
sequence-specific. For example, the Pneumocystis ribozyme was previously shown in
vivo to be capable of cleaving a second site within its target RNA transcript. To address
this concern, the Pneumocystis ribozyme could be reengineered to include an extended
guide sequence (83, 84, 86-90) to aid in enhancing the binding of the ribozyme to the
intended RNA transcript. Though there are many questions still to be answered for the
TES reaction, the mechanistic investigation presented in this work has laid a foundation
for future studies for improving the overall TES reaction in vitro and in vivo.
Kinetic Characterization of the Substrate Cleavage Reaction of the TES Reaction
The work presented herein has established a kinetic framework for the substrate
cleavage step of the TES reaction. Several conclusions can be drawn from the kinetic
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framework, including that the rate constant for the substrate cleavage reaction is
approximately 60-fold lower than a previously reported Tetrahymena thermophila
ribozyme. The rate constant for substrate cleavage is only 4-fold greater than that for
substrate dissociation. Furthermore, the rate of product dissociation is slower than the rate
of substrate cleavage, which curtails the possibility of multiple-turnover reactions. Lastly,
the results indicate that a conformational change exists between the two steps of the TES
reaction.
The kinetic study has been informative for increasing our understanding of the
fine details by which the substrate cleavage step proceeds. The conclusions that can be
drawn from the kinetic data, however, suggest strategies whereby we could enhance the
rate and yield of the substrate cleavage reaction. For example, the relatively slow rate of
product dissociation is potentially rate-limiting for any potential multiple-turnover
reactions. To increase the rate of product dissociation, the ribozyme could be
reengineered to weaken the binding of TES products, for example by shortening helix P1.
A shortened P1 helix has previously been shown to increase the rate of product
dissociation for a group I intron-derived ribozyme from Anabaena (72).
Separately, the rate of substrate dissociation was shown to be comparable to the
rate of substrate cleavage. This suggests that a substantial amount of substrate will
dissociate prior to the substrate cleavage reaction. To slow the rate of substrate
dissociation, the ribozyme could be reengineered to strengthen the binding of TES
substrates, for example by elongating helix P1. Elongating helix P1, however, could
strengthen the binding of TES products, which could decrease the rate of product
dissociation even further. Therefore, TES ribozymes would have to be designed to
include a P1 helix, of optimal length, to overcome the limitations set by the rates for
substrate and product dissociation. Lastly, the length of helix P1 would have to
investigated to determine the effects upon the specificity of the TES reaction.
Group I Intron-Derived Ribozyme Catalyze the Trans Excision-Splicing Reaction
The work presented herein has demonstrated that the TES reaction is generally
applicable to other group I intron-derived ribozymes. A group I intron-derived ribozyme
from Tetrahymena thermophila and Candida albicans were shown to catalyze the
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excision of a single nucleotide from within their respective RNA substrate. Moreover,
both ribozyme constructs catalyze the substrate cleavage step through an intramolecular
transesterification reaction, similar to the Pneumocystis carinii ribozyme. The
Tetrahymena and Candida ribozymes, however, were shown to catalyze the individual
steps of the TES reaction less efficiently than the Pneumocystis ribozyme. The decrease
in efficiency was attributed to the Tetrahymena and Candida ribozymes inability to
effectively bind their terminal guanosine into the GBS. To increase the ribozymes affinity
for their terminal guanosine, the ribozymes’ RE2 recognition elements, could be
modified (to form helix P9.0) to aid in aligning their terminal guanosines.
That additional group I intron-derived ribozymes can catalyze the TES reaction,
raises questions with respect to the role of these ribozymes in vivo. Group I intronderived ribozymes are essentially exon-less introns that mimic the final intron (L-IVS)
product after self-splicing occurs. It has previously been shown that these spliced-out
introns undergo intramolecular cyclization reactions, resulting in a predicted inactive,
circular intron product. However, it is not known if these spliced-out introns can catalyze
additional intramolecular transesterification reactions. This could include spliced-out
introns catalyzing the TES reaction using additional RNA transcripts as substrates. If,
however, these spliced-out introns catalyze the cleavage of RNA transcripts that code for
essential protein products, this could have deleterious effects on a cell. With this in mind,
the intramolecular cyclization reaction could have evolved to deactivate spliced-out
introns from cleaving unintended RNA transcripts.
The Trans Insertion-Splicing Reaction
The trans insertion-splicing (TIS) reaction has been envisioned as a new strategy
for the construction of RNA transcripts with site-specific modifications. In this strategy,
the Pneumocystis carinii ribozyme would be engineered to insert specific regions from
within full-length RNA transcripts. In turn, these modified RNA transcripts could be
useful for functional as well as structural studies of RNA in vitro and in vivo. The work
presented herein has answered some of the questions relating to the feasibility of using
the TIS reaction as a strategy for site-specific incorporation of modified oligonucleotides
into RNA.
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The Trans Insertion-Splicing Reaction can Catalyze the Insertion of Modified
Oligonucleotides
The work presented herein has demonstrated that the TIS reaction is a viable
strategy for the insertion of modified oligonucleotides into an RNA substrate. In the
current study, key positions within a nucleotide were altered, including changes to the 2’
position of the sugar ring, the phosphodiester backbone, and the base positions.
Modifications at each of these positions can be used as probes for investigating the
underlying intricacies of a specific RNAs structure and function. For example, the TIS
strategy could be useful for the insertion of spin labels for electron paramagnetic
resonance (EPR) or for labeling RNA sequences with relevant isotopes for nuclear
magnetic resonance (NMR) studies. In addition, TIS could be used for labeling RNA
sequences with fluorescent probes for use in fluorescent resonance energy transfer
(FRET) experiments. Finally, the role of post-transcriptionally modified RNA transcripts
could be more thoroughly investigated through creation of these RNA transcripts using
the TIS strategy. With the broad range of modified nucleotides that are commercially
available, future TIS reactions could potentially open new avenues for the study of RNA.

Copyright © Perry Patrick Dotson II 2008
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